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Human Immunodeficiency Virus (HIV) remains a significant public health problem in 
Sub-Saharan Africa with poor treatment outcomes in children and adolescents (C&As).  
There is a lack of information on the effects of various HIV care models (Child and 
Adolescent Friendly Clinic model and Support Group model) on retention in care and 
Viral Suppression (VS) in Cameroon. This study was carried out to identify the care 
model with the best outcomes for C&As, inform national scale-up strategies, resource 
prioritization, and contribute to the existing literature. A quantitative retrospective cohort 
review approach guided by the social cognitive theory was used to analyze data on 2,503 
C&As aged 0-19 years current on antiretroviral therapy (ART) from January 2018 to 
September 2019 with a documented viral load result. Data were analyzed using multiple 
logistic regression and the Kruskal-Wallis one-way analysis of variance tests, and 
findings were interpreted using the test statistics and p values. The retention at 12 months 
was not associated with the model of care (OR = 1.014, p = .876). Viral Suppression and 
medication pickup were not associated with the type of home-based caregiver. The Odds 
of VS were 1.265 times higher in C&As enrolled in the Child and Adolescent Friendly 
Clinic model compared with the Support Group model (p = .003). Consequently, this 
research's findings will impact positive social change by stimulating further studies 
leading to quality improvement in the HIV domain. Moreover, the results could 
encourage public health professionals to design and implement effective HIV 
management programs addressing clinical and psychosocial services needed to improve 
retention and VS for C&As.  
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Chapter 1: Introduction to the Study 
Introduction  
This study was carried out to identify the model of care among the three used in 
the field that offer the best retention and viral suppression rates in children and 
adolescents (C&As) on antiretroviral therapy (ART). The findings will inform human 
immunodeficiency virus (HIV) stakeholders on the strategy to invest time and resources 
as they seek higher viral suppression rates in C&As. There is currently a lot of investment 
in all three models. Still, viral suppression rates for this population remain lower than 
70% (CAMPHIA, 2018). This study equally can promote program effectiveness leading 
to positive social change among national decision makers and program implementers in 
Cameroon, which is in line with the mission of Walden University.  
This chapter includes a statement of the social and research problems based on 
existing literature, the study purpose, the research questions, hypotheses, the theoretical 
framework, the nature of the study, the variable definitions and data collection method, 
assumptions, scope/delimitations, limitations, significance, and positive social change 
implications. 
Background 
HIV remains a significant public health problem in several countries in the sub-
Saharan African (SSA) region (Abrams et al., 2016). There is still no cure for HIV, but 
the use of ART has dramatically reduced HIV-associated morbidity and mortality in 
people living with the virus in SSA (Haas et al., 2019; Kukoyi et al., 2016). Cameroon is 
one of the countries in the SSA region with many unidentified people living with HIV 
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and low HIV viral suppression rates among those on ART. According to the Cameroon 
Population-Based HIV Impact Assessment conducted in 2017, only 46.9% of those living 
with HIV aged 15 to 64 years knew their HIV status, whereas 80.0% of those in the same 
age group on ART had viral suppression (CAMPHIA, 2018). These statistics are much 
lower for children living with HIV in Cameroon as only a small proportion of them are 
on ART (Penda et al., 2019). Those on ART have low viral suppression rates than adults 
(Billong et al., 2016a). Identifying and scaling up high-impact strategies for managing 
C&As living with HIV may hasten the progress towards an HIV-free generation.  
People living with HIV need to stay in care and adhere to treatment to achieve 
viral suppression. Adherence is crucial for treatment success (Mimiaga et al., 2018) and 
is a significant challenge in the SSA region (Mazenga et al., 2017). Adherence to ART is 
a more substantial challenge in children and youths who need additional support from 
their parents or caregivers (Closson et al., 2019). People who are not regular in HIV care 
cannot be adherent and are likely to have poor treatment outcomes, usually assessed by 
measuring their viral load (El-sadr, Rabkin, Nkengasong, & Birx, 2017). Cameroon has 
recorded significant strides in the fight against HIV, reducing the national prevalence 
from approximately 10% in early 2000 to 3.7% in 2018 (CAMPHIA, 2018). However, 
the first semester national report of 2017 showed a continuous increase in HIV positive 
cases identified and initiated on ART. It also showed significant gaps in the ART 
initiation rate for those tested HIV positive, low uptake of viral load testing, and 
suboptimal viral suppression rates (NACC, 2017). Various factors account for the low 
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retention rates, poor adherence, low viral suppression rates, and treatment failure, 
including the strategies used to deliver the patients’ services. 
The national HIV program in Cameroon has recorded low rates of ART initiation 
and retention in HIV care through the years. A cross-sectional study that assessed 
retention in HIV care for a 1-year cohort of patients from 56 sites in the country’s 10 
regions found a 60% retention rate at 12 months (Serge Clotaire Billong et al., 2016a). 
According to the national programmatic reports of 2017, only 49.5% of the expected 
number of people diagnosed with HIV were on ART, and retention in HIV care was 
between 76.6% and 79.2% (NACC, 2017). The national report contained data from all 10 
regions of the country and was representative of Cameroon’s situation, though with 
internal variations across geographic areas. Figure 1 shows an estimated 561,107 people 
living with HIV in Cameroon in 2017, but only 58.4% knew their HIV status, and only 












Figure 1  
The HIV Treatment Cascade by 2017 in Cameroon (adapted from the first Semester 
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Figure 2  
The 12-month retention rates in selected cohorts of people on ART in Cameroon in 2017 





Figure 2 shows evidence that none of the six cohorts monitored after 12 months 
on ART had up to 80% retention rate, which indicates the failure to achieve the 90% 
United Nations AIDS (UNAIDS) viral suppression target for the country (UNAIDS, 
2014). Evaluating the national program to identify and address major gaps in HIV case 
identification and retention in care inevitable if Cameroon desires to achieve the UNAIDs 
90 90 90 targets. 

































suppression rates for those who did the test were less than 90% (CAMPHIA, 2018). A 
study to estimate the national viral suppression rate using a nationally representative 
sample found 72% viral suppression for a cohort of patients 12 to 24 months after ART 
initiation and 68% for another cohort 48 to 60 months after ART initiation (Tchouwa et 
al., 2018). This study also found out that patients with unsuppressed viral load in 
Cameroon had high indications for HIV drug resistance, which was already identified in 
previous studies (Billong et al., 2012; Billong et al., 2013; Billong et al., 2016b). The 
national report of 2017 presented a viral suppression rate of 76.5% for the country. 
Unfortunately, the various papers and national reports did not report children’s specific 
suppression rates, which indicated limited attention to this subpopulation. These findings 
confirm the urgency for research that focuses on C&As precisely and the need for 
identifying implementation strategies that yield maximal results to reduce the likelihood 
of treatment failure in C&As.  
The Vulnerability of C&As 
C&As fall into the group of vulnerable populations. They are generally dependent 
on their parents or caregivers for their health and well-being (Enane et al., 2018b). C&As 
are more vulnerable to infections because they have no power to control where they live, 
what they eat, and their community interactions. They are equally more likely to default 
from HIV care since HIV infections may reduce their immunity, making them more 
vulnerable to other infectious and health hazards than non-HIV infected children (Bate et 
al., 2016; Flanagan, Cunningham, Lewis, Tobin, & Ickovics, 2019). Their increased risk 
of defaulting from HIV care puts them at a higher risk of being virally unsuppressed and 
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developing treatment failure (Boerma et al., 2017). They need regular reminders to take 
their medications and depend on their parents or caregivers for transportation to the 
clinics for a drug pickup. Some of the parents or caregivers also need constant reminders 
for a medication pickup as demonstrated in a study of the effect of cell phone calls and 
messages on the respect of pickup appointments by Bigna, Noubiap, Kouanfack, Plottel, 
and Koulla-Shiro (2014). Researchers in Asia found out that children who are orphans 
(not living with their biological parents) are more likely to default from treatment and 
have poorer outcomes than those living with their biological parents (Huy et al., 2016a). 
These and many other factors contribute to the lower treatment adherence and retention 
in care for C&As compared with adults (Closson et al., 2019). The home care provider’s 
effects on HIV treatment outcomes in C&As has not yet been documented in Cameroon.  
Models of Care Used to Deliver ART and Keep Children and Adolescents in Care 
Various care models have been used to provide ART to C&As in different countries 
with varying results. For instance, in Zimbabwe, researchers assessed the effect of 
community-based support for caregivers on virologic failure in children from 6 to 15 
years on ART using an open-label randomized control trial. They found out that 
community support to caregivers showed substantial benefits on viral suppression in 
children (Ferrand et al., 2017). Another study by Lee et al. (2016) documented higher 
retention and viral suppression rates in youths attending an environmentally friendly 
clinic than those attending the regular clinic. A clinical trial assessing the use of a 
streamlined care model in Uganda and Kenya also showed higher retention and viral 
suppression rates in the intervention group (Kwarisiima et al., 2017). Some other 
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researchers in Uganda evaluated the effectiveness of an intensive adherence counseling 
(IAC) strategy to improve treatment outcomes in 345 C&As from 9 months to 19 years in 
15 public health facilities. They found out that only 23% of the children achieved viral 
suppression after completing the three sessions of IAC within a mean follow-up period of 
113 days, which cast doubts on the effectiveness of the strategy (Nasuuna, Kigozi, 
Babirye, Muganzi, & Sewankambo, 2018). Pediatric care services in Cameroon have 
used similar strategies in different clinics at different time points. Still, the persistently 
low viral suppression rates cast doubts on the effectiveness of these models. Most of the 
studies highlighted demonstrated the efficacy of various care models and innovative 
strategies, except the Ugandan study. The existing literature did not have any research 
that compared outcomes among different care models. Comparing viral suppression rates 
for the Cameroon care models could help prioritize the most successful model for the 
national scale-up plan. Still, it could also feel a gap in the existing literature in this 
domain. 
Most of the funding for HIV services in Cameroon comes from external sources. 
According to the 2017 First Semester National Report on HIV activities, 88.3% of all 
finances used for HIV activities came from external sources with the Global Fund and the 
American President’s Emergency Plan for AIDS Relief (PEPFAR) as major funders 
(NACC, 2017). A study by Zakumumpa, Bennett, and Ssengooba (2017) highlighted that 
global funding for HIV programs is flattening, and countries need to seek alternative 
funding sources to sustain their HIV programs. In such circumstances, it becomes even 
more critical to invest only in programs that yield the best effects on the population. 
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Providing the best care model for patients could save cost, effort, and time. The study 
sought to identify evidence for the best HIV care model for C&As that could be 
promoted for scale-up in Cameroon. 
Problem Statement 
HIV remains a significant public health concern in SSA. Many countries in the 
SSA region are still far from achieving the UNAIDS ambitious treatment targets for 
ending the AIDS epidemic in their pediatric and adolescent HIV programs (Elgalib et al., 
2018; Enane et al., 2018a; Peter et al., 2017). These targets stipulated that by 2020, all 
countries fighting to end the AIDS epidemic should identify 90% of all people living with 
HIV, initiate at least 90% of those identified on treatment, and achieve 90% viral 
suppression for those on medication (UNAIDS, 2014). Research findings from Cameroon 
documented alarming unsuppressed viral load levels and low retention in the pediatric 
and adolescent care cascade (Tchouwa et al., 2018). The inadequate viral suppression 
indicates the possibility of drug resistance in this subpopulation (Billong et al., 2016). 
These C&As have undesirable outcomes and high mortality rates (Bigna et al., 2014). 
They are usually sick, unable to attend school regularly, and often on admission in the 
hospitals (Bate et al., 2016). Families spend money on hospital bills instead of food and 
other needs; mothers spend time taking care of sick children instead of fending for their 
families, increasing their poverty level. Furthermore, the interventions implemented in 
most countries target C&As in general, but C&As who do not live with their biologic 
parents have special needs that may affect their retention in HIV care and medication 
adherence, leading to reduced viral suppression (Huy et al., 2016b).  
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In the last 5 years, Cameroon has implemented various care models and strategies 
on a limited scale to improve treatment outcomes for pediatrics and adolescents on ART. 
For instance, some health facilities in urban and rural settings in the past 5 years used 
children and adolescent-friendly clinics and support groups to manage C&As living with 
HIV. The C&As come together monthly to play, share experiences, and receive 
psychosocial support. However, there was no significant improvement in the outcomes in 
C&As, especially in the regions where these models were widely implemented according 
to national reports (NACC, 2014 and 2017). No researcher in Cameroon has evaluated 
the various HIV care models’ contribution to their HIV care retention and subsequent 
viral suppression. Identifying which of the care models is associated with higher retention 
in care and viral suppression rates for C&As in HIV care could inform national scale-up 
strategies and resource prioritization. The results would also contribute to the existing 
literature on maximizing the outcomes in C&As on ART.  
Purpose of the Study 
The purpose of this study was to generate evidence on retention in care and viral 
suppression for the C&As on ART in Cameroon while identifying the care model with 
the best outcomes. Thus, I compared various HIV care models used to manage the C&As 
to identify the care model among the three with the best retention in care and viral 
suppression. I also hoped to establish if the type of care provider at home is associated 
with retention and viral suppression in C&As on ART in Cameroon. The findings will 
contribute to the existing literature gap and inform program planning, funding 
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prioritization, and national program scale-up strategies that promote specific high-impact 
interventions. 
The study used a quantitative retrospective cohort monitoring approach to 
examine existing information in hospital medical records. The study’s primary outcomes 
were retention in care within 12 months, viral load status (suppressed or unsuppressed), 
and medication pickup consistency within the 12 months. The exposure variables were 
the care models used to manage the C&As and their type of care provider at home. The 
study also included information on possible confounders like age and sex, which were 
systematically documented in medical records. I hoped to analyze the data and identify 
which of the care models yielded the best outcomes in Cameroon's routine HIV program 
and indicate whether C&As living with their biologic parents had higher viral 
suppression rates than those living with foster parents.  
Research Questions and Hypothesis 
The study had four main research questions as follows. 
Research Question 1(RQ1). Is there an association between the 12 months’ 
retention in HIV care and the HIV care model used for C&As after controlling for age 
and sex?  
Null Hypothesis (Ho1): There is no significant association between the 12 
months’ retention in HIV care and the HIV care model used for C&As on ART after 
controlling for age and sex. 
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Research Hypothesis (Ha1): There is a significant association between the 12 
months’ retention in HIV care and the HIV care model used for C&As on ART after 
controlling for age and sex.   
Research Question 2 (RQ2). Is there an association between viral suppression 
and the HIV Care model used for C&As after controlling for age and sex?  
Null Hypothesis (Ho2): There is no significant association between viral 
suppression and the HIV care model used for C&As after controlling for age and sex. 
Research Hypothesis (Ha2): There is a significant association between viral 
suppression and the HIV care model used for C&As on ART after controlling for age and 
sex. 
Research Question 3 (RQ3). Is viral suppression associated with the type of the 
home-based care provider (the person who supports the child or adolescent at home) 
among C&As on ART in Cameroon? 
Null Hypothesis (Ho3): Viral suppression is not significantly associated with the 
type of home-based caregiver (the person who supports the child or adolescent at home) 
among C&As on ART in Cameroon? 
Research Hypothesis (Ha3): Viral suppression is significantly associated with the 
type of home-based care provider (the person who supports the child or adolescent at 
home) among C&As on ART in Cameroon?  
Research Question 4 (RQ4). Is there a significant difference in the average 
proportions of the consistency in medication pickup for the different types of home-based 
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care providers (the person who supports the child or adolescent at home) among C&As 
on ART in Cameroon?  
Null Hypothesis (Ho4): There is no significant difference in the average 
proportions of the consistency in medication pickup for the different types of home-based 
providers among C&As on ART in Cameroon.  
Research Hypothesis (Ha4): There is no significant difference in the average 
proportions of the consistency in medication pickup for the different types of home-based 
providers among C&As on ART in Cameroon  
Collecting data and analyzing to respond to these four research questions led to 
achieving the study’s objectives. I hypothesized that children enrolled in children and 
adolescent friendly clinics (CAFCs) will have higher retention and viral suppression than 
those not enrolled in such social groups. Also, I speculated that children living with their 
biological parents received better parental care and were likely to have better viral 
suppression rates than those living with other caregivers. This study generated 
substantiation, as presented in Chapter 4, either confirming or disproving these 
hypotheses.  
Measurement of Variables 
Viral Load Status 
According to the nationally approved algorithm, patients on ART are supposed to 
have a viral load test at least once a year. The viral load is measured in terms of viral 
copies per milliliter of blood. In Cameroon, the values obtained are classified into three 
categories: not detectable (0 copy/ml), detectable but <1000 copies/ml, and detectable 
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with >1000copies/ml. Those not detectable or detectable with <1000 copies are classified 
as virally suppressed, while those with >1000 copies/ml are virally unsuppressed (Collins 
et al., 2019). 
Retention in Care 
Viral suppression was measured by taking the cohort of patients in care at the start 
of the study period and documenting the number still in care after 12 months. Viral 
suppression was recorded for the C&As who started treatment within the study period 
and attained 12 months on ART before December 2019. Retention rates were calculated 
per care model and findings reported. 
Consistency in Medication Pickup 
Patients on ART pickup medications each month, and the information is documented in 
the ART registers against the said month. When they miss picking up medications for a 
month, space is left blank to indicate a missed opportunity. For this study, the number of 
months with documentation of medication pickup in the last 12 months will be recorded. 
The proportions of the consistency in medication pickup will be calculated for each client 
using 12 months as the denominator and the total number of months the C&As picked 
medication (as recorded in the ART register) as the denominator and the analysis of the 
information will generate the responses to the fourth research question. 
Care Models 
Different health facilities use various care models to manage C&As based on their 
external support. These care models are different from the differentiated care model 
promoted by WHO (Graves et al., 201; Prust et al., 2018) in that the model is used for all 
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the patients and not adapted to individual needs. This study’s care models were children 
and adolescent-friendly clinics, support groups, and standard clinic visits. Sites selection 
was purposeful, considering the model of care used onsite to have a near equal 
distribution of participants in the various models. 
The Type of Home-Based Care Provider 
The type of caregiver supporting each study participant at home was documented and 
classified into three main categories: (a) both parents; (b) one parent (mother alone of 
father lone); and (c) foster parents/caregivers who included aunts, uncle, brother, sister, 
and others.   
Possible confounders or effect modifiers with information documented in the 
client records were age and sex. These two were included because there was data 
available on them in the registers and because some published studies showed that 
retention and viral suppression were associated with age and sex.  
The Theoretical Framework Guiding the Study 
The theory that guided this research was the social cognitive theory (SCT), which 
was first articulated by Bandura in a book titled Social Foundations of Thought and 
Action (Bandura, 1986). This theory holds that personal factors, environmental 
influences, and behavior continually interact in a dynamic three-way reciprocal manner 
(Glanz & Bishop, 2010). The theory has been used to guide interventions that include 
learning from observations, setting goals to drive behavior change, and reinforcing 
behavior (Forthofer et al., 2016). It builds on the fact that an enabling environment and 
personal factors can influence behavior leading to self-efficacy, which is the confidence 
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in the ability to do things in specific circumstances (Forthofer et al., 2016). C&As 
constitute a population that is still dependent on their parents and caregivers in terms of 
where they live, what they eat, financial resources, and, to a great extent, what they 
know, social protection, and their decisions (Bröder et al., 2017). They need money from 
their parents or caregivers to go for medication pickup, require information from them on 
why they are taking the medications, and need reminders when taking the medicines. 
They are also fast learners and quickly learn and develop the confidence to perform 
specific tasks when given the enabling environment. 
Applying these facts to the study, the SCT was used to explain the 
parental/caregiver support children receive at home, the therapeutic sessions, play 
sessions, and enhanced adherence counseling sessions received in the clinics in addition. 
It was also be used to explain the effect of their interactions with the care providers and 
their peers, which might have influenced their retention in care, adherence to therapy, and 
viral suppression. Their engagement in all these activities might have increased their 
understanding of the importance of staying in care (Bröder et al., 2017), improved their 
self-confidence, and the determination to stay healthy (Forthofer et al., 2016). In line with 
the hypothesis, C&As enrolled in the care models and living with both parents might 
have more favorable conditions that improved their social cognitive behavior and ability 
to stay in HIV care, achieve viral suppression than those living with foster parents. 
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Nature of Study 
Methodology 
This study was quantitative, using a retrospective cohort review approach to 
analyze data on child and adolescents (0-19 years old) who were currently on ART in 
HIV programs in Cameroon from January 2018 to September 2019. I selected this 
approach because of the limited cost involved and the convenience of using existing data. 
The outcome variable’s data was quantitative and already existing in health facility 
registers and patient medical files. The data on exposure variables was categorical data 
also existing in the medical records. I used a convenient sample of study sites that I 
purposefully selected following the number of children enrolled in care and the various 
care models implemented while maximizing a mix of urban versus rural communities, 
public versus private health facilities, and English versus French-speaking regions. At the 
sites, all clients on ART aged 0 to 19 years who had been on ART for at least 1 year and 
had done at least one viral load test were included based on the results documented in the 
medical records. The records’ review allowed the tracking and documentation of 
demographic information, type of care providers at home, viral suppression status, and 
other variables. I entered the data into an Excel sheet on the computer, cleaned the data, 
and analyzed the data using SPSS Version 25. 
Study Variables, Data Sources, and Data Analysis 
I collected data on numbers of C&As enrolled and with documented viral load 
results in each participating site and disaggregated the data by care model, age, sex, and 
type of home-based caregiver. Care models included CAFCs, support groups (SGs), and 
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standard clinic visits (SCVs). The C&As were divided into four age groups: <5 years, 5 
to 9 years, 10 to 14 years, and 15 to 19 years to ease the provision of age-adapted 
therapeutic education with those in the group of 15 to 19 years considered as adolescents. 
For this study’s purpose, I divided them into two groups with those ≤14 years seen as 
children and those ≥15 years seen as adolescents. The type of home-based caregivers 
included three categories: (a) both mother and father; (b) mother or father alone; or (c) 
foster parents who included aunt, uncle, grandparents, sister, brother, or others.  
Data Analysis Plan 
After data cleaning, coding, and transfer to SPSS (v.25), the data analysis began 
with exploration using various statistics, percentages, and frequencies to examine and 
present the data. The descriptive analysis findings were presented using frequency tables, 
some bar charts, and pie charts for categorical variables. I used tables, central tendency 
measures, and variation measures, such as means, median, standard deviations, variance, 
range, and confidence intervals, for continuous variables. I used the binary logistic 
regression model to predict the probability of achieving good retention in care and viral 
suppression in the three models of care as hypothesized. I also constructed multiple 
logistic regression models, including the exposure variables and the two possible 
covariates (age, sex) to assess their effect on the associations between the outcome in the 
three models of care and caregiver categories. To respond to RQ4, which had a 
continuous outcome variable, I used the Kruskal-Wallis one-way-ANOVA test to 
examine the difference in the mean proportions of the consistency in medication pickup 
recorded for each type of care provider and interpreted the F statistic. Finally, I used 
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appropriate tables to present the results of the inferential statistics. The findings were 
interpreted using the p-values, alpha, and effect sizes obtained with an alpha of equal to 
or less than .05 were considered significant.   
Study Approval 
I obtained approval at various levels before carrying out the study. These included 
the National Ethics Committee in Cameroon, the Cameroon Baptist Convention Health 
Board (CBCHB), Institutional Review Board (IRB), the Walden University IRB, and 
administrative letters of support from the leaders of all the 27 selected health facilities. I 
needed the approval of the national Ethics Committee in Cameroon because my study 
involved five of the country’s 10 regions. That of the CBCHB was also required because 
seven of the 27 study sites were CBCHB health facilities. I also had to visit and collect 
the administrative support letters from all the health facilities involved as a requirement 
for the study’s approval by the National Ethics Committee. After these approvals, I 
moved unto data collection from the sites using a data abstraction form. I reviewed 
existing hospital registers and patient files for C&As enrolled in HIV care and extracted 
data on the variables of interest using the data abstraction form developed for the study. 
The data abstraction included only codes for the clients and not their names or other 
identifiable information to maintain confidentiality. I did the data collection personally 
with support from two trained research assistants who have good experience working 
with ART registers in HIV clinics to limit any chances for breach of confidentiality while 
maximizing the quality of the data collected.  
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Definition of keywords 
Retention in care. People who are retained in care consistently respect their 
medication pickup appointments without missing the appointment date for up to a week. 
People who neglect their appointment dates for 7 to 90 days are called defaulters, while 
those who miss their appointment for more than a period of 90 days are referred to as 
lost-to-follow-up. HIV treatment programs in Cameroon are implementing the 
differentiated care models which tailor the appointment dates to the needs of specific 
clients (Boeke et al., 2018). However, most children have monthly appointment dates. 
Those who belong to the various care models, such as play corners or adolescent clinics, 
receive their medication on the days for club activities that hold monthly. 
Viral suppression. The viral load test is used to assess the level of HIV in the 
blood of those living with the virus and measures the number of copies in a milliliter of 
blood. A blood sample with more than 1000 viral copies per milliliter (ml) of blood is 
considered virally unsuppressed while that with less than 1000 viral copies/ml of blood is 
considered virally suppressed (Collins et al., 2019). C&As have lower viral suppression 
rates (Chime et al., 2018), and patients who are virally suppressed have higher chances of 
staying healthy and reduced chances of transmitting the virus to another person (Enane et 
al., 2018b).   
Models of care. A care model refers to the service delivery model used to manage 
the patients. Some C&As in Cameroon attend the regular clinic visits, receive services in 
groups during age-adapted support group sessions in the clinic or monthly child-play 
corner activities in the clinic or through monthly adolescent-friendly services organized 
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by the clinics. In the CAFCs, services providers make sure that C&As receive both 
clinical and psychosocial care services during group activities while interacting with each 
other. Children who attend only standard clinic visits miss the peer interaction and 
therapeutic education provided during the sessions. Some of those who participate in 
regular clinic visits receive counseling as needed but often limited compared with that 
offered in the other care models. For this study’s purpose, the participants were classified 
into the three groups coded as SG, SCV, CAFC, and data analyzed by such groups. 
The caregiver of C&As at home. The focus of family status was on the people 
who provide care to the children at home. These could be their two biological parents, 
single parent, or foster parents. The interest was to see if C&As who live with their two 
biologic parents had better viral suppression rates than the other children. Each of the 
study participants fell into one of these three groups.  
Antiretroviral therapy. This is the medication given to people living with HIV, 
which they take daily and will continue taking for life or until when there will be a cure 
for HIV. Clinicians use various combinations to manage patients depending on the 
disease stage or viral suppression status and the national treatment protocols.  
Children in the study. These and individuals aged from 1 day to 14 years old 
living with HIV and on ART in one of the selected study sites. 
Adolescents in the study. These are individuals aged 15 to 19 years who were 
living with HIV and on ART in one of the selected study sites. 
Medical records. These included national registers in the clinics in which service 
providers recorded information on essential services offered to the patients following 
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nationally approved indicators. They included longitudinal information per patient, which 
the service providers format after every 2 years, given the limited space on the hard 
copies. Each patient also had a medical file that contained more personalized 
demographic and medical follow-up information on additional indicators that could not 
fit into the registers. 
Assumptions 
This study’s key assumption was that the registers and medical files’ information 
would be complete enough to facilitate the data abstraction process. This assumption was 
not valid in all cases, and it became necessary to use the two documents before obtaining 
complete data for some patients. This study required complete information on the 
variables included. I assumed easy access to complete data, which facilitated data 
abstraction and attaining the required sample size. This study depended on existing 
information with no access to the participants to verify the information recorded for them. 
I also assumed that the documented information for each participant in the registers was 
accurate and reliable. Otherwise, it would have been a waste of time, and findings will 
not represent the country’s situation if the data recorded in the registers and medical files 
were not accurate. 
Scope and Delimitations 
I looked at viral suppression status in C&As served through three models of care 
in Cameroon. I also compared viral suppression rates among the C&As based on their 
type of caregivers at home. The study was limited to retention, viral suppression, 
consistency in medication pickup, and the two main exposure variables for the following 
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two reasons: the C&As were those with the lowest viral suppression rates in the country 
and high-impact strategies were needed to improve their care and outcomes. Second, 
some program implementers assumed that the type of home-based caregiver had a 
significant effect on treatment outcomes for C&As. Bringing out evidence on these two 
points could significantly contribute to the existing evidence on HIV management in 
C&As.  
This study focused on C&As enrolled on ART through various health facilities in 
Cameroon. The selection of sites was limited to five of the 10 regions in Cameroon, 
limiting the generalizability of the findings. The five regions included Center, Littoral, 
Southwest, Northwest, and West. These involve three French-speaking and two English 
speaking regions. These regions are those where various care models have been used 
within the last 5 years in pediatric care and provided the needed sample size. Also, the 
number of people living with HIV and on ART in Cameroon in these five regions in 2017 
represented 76.3% of the total number of people on ART in the entire country (NACC, 
2017), which increased the generalizability of the study results.  
Limitations 
The study was a retrospective cohort study, which has advantages over cross-
sectional studies and has limitations. Longitudinal studies do not include the 
randomization of participants and are, therefore, prone to systematic bias in the 
assignment of participants in the group (Richards, Brown, Barley, Chong, & Thomson, 
2018). The study depended on existing information in medical records, and the 
significant barrier that might have occurred during data collection was the absence of 
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complete data in the existing files due to inadequate documentation of services offered. 
Other variables of interest, such as socioeconomic status or parents’ level of income, 
could not be included because there was no existing information on such variables in the 
records. These would have been included if the study was prospective in nature. I 
coordinate HIV activities in various regions and did not have challenges with access to 
information once the study received approval from the Walden University, facility 
leaders, CBCHB IRB, and the National Ethics Committee. However, there could be 
challenges with separating the role of a supervisor from that of a researcher. Conscious of 
this possible conflict, I ensured to keep a neutral researcher position as much as possible 
and introduced myself in each facility as a researcher while presenting the various ethical 
approvals and followed the procedures in place for every researcher collecting data from 
the facility. The study also focused on those C&As already on ART and those living with 
HIV who were not yet on ART were left out, whereas some might not be on ART yet due 
to their family status or type of home-based caregiver.  
The significance of the study 
There is a need to prioritize health interventions that yield the best results, which 
have a more significant effect on the population. This prioritization was more critical in 
settings where there are competing health priorities, and the resources to fight the HIV 
pandemic are limited (Zakumumpa et al., 2017). This study has the potential to promote 
positive social change at the decision making and program implementation levels in 
Cameroon and the SSA region, which is in line with the mission of the Walden 
University. Findings from this study will fill a gap in understanding which model of care 
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yields the best outcomes for C&As living with HIV and on ART in routine care settings 
in Cameroon. These findings may also be useful in other SSA countries with similar HIV 
care challenges such as Congo, Nigeria, and Ivory Coast (Enane et al., 2018b). The study 
findings will open other areas for research, given the limited existing literature on some 
aspects of the study, such as home-based caregivers’ role. 
The study findings also have the potential to promote social change at the clinic, 
community, and health system levels as follows: 
• At the clinic level, the results will likely increase providers’ and parents’ 
understanding of the quality of life of C&As living with HIV, which may enable them 
to strengthen the care they provide to the C&As both in the clinics and at home. 
• At the community level, the study findings may affect the understanding of the actual 
burden of HIV, the plight of C&As living with the virus, and the support they need 
from the community to stay healthy and be virally suppressed. For instance, as many 
more of the C&As living with HIV achieve and sustain viral suppression and live 
healthy lives, viral transmission rates will be low, they will attend school regularly, 
their parents and caregivers will spend less money on their health, less time in 
hospitals, and have more time to work and generate money for other family needs. 
• At the health system level, the study findings will inform health stakeholders in 
Cameroon and other countries with similar challenges during planning, prioritization, 
and the allocation of the limited financial resources to invest in models of care that 
yield the best outcomes. These findings will equally inform program implementers to 
spend time and efforts on the models and strategies that produce the best results and 
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facilitate the achievement of the third 90 UNAIDS goal in C&As, which aims to have 
at least 90% of all patients on ART virally suppressed. 
Summary 
People living with HIV need to stay in care, adhere to treatment, and achieve viral 
suppression to live healthy lives. In this chapter, I presented an introduction and the 
background of my proposed study. I also introduced the problem statement and the 
study's purpose, highlighting the research problem and objective, leading to the research 
questions I wished to answer by the end of the study. I stated the research questions and 
the research and null hypotheses that were confirmed or disproved by the study findings, 
as seen in chapter four. I highlighted the SCT, which grounded the study, and presented 
the study’s nature, which used a quantitative methodology. I equally provided some 
definitions for key terms, scope, delimitations, assumptions, and discussed the limitations 
and social change implications. In Chapter 2, I will review and present recent literature 
on the topic, especially from the SSA region.   
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Chapter 2: Literature Review 
Introduction 
Retention in care is still a challenge in the pediatric and adolescent HIV program in 
Cameroon. Low retention in care leads to poor outcomes increasing morbidity and 
mortality, and increases HIV transmission in adolescents (Enane et al., 2018a). Although 
viral load testing coverage is not up to expectation, viral suppression rates for C&As 
tested remain lower than those of adults. Various care models are used to manage C&As 
enrolled on ART in various clinics in Cameroon, but the continuous low viral suppression 
rates put to question these models’ effectiveness. Service providers suggest that the 
C&As have low viral suppression rates because many of them are orphans and do not 
have their parents as the primary care providers at home. Although no documented 
evidence compares the performance of the outcomes in these three models of care, there 
is no evidence for an association between these outcomes and the type of care provider to 
the C&As at home.  
By conducting this study, I aimed to compare retention in care, and viral 
suppression rates for C&As on ART served through three care models to identify which 
methods offer the best retention and viral suppression rates. I also aimed to assess the 
association between the type of care provider at home and viral suppression for the C&As 
enrolled in this study. This study could generate evidence that will inform the national 
scale-up of interventions to improve viral suppression rates. The findings from this study 
could also contribute to the existing literature on the models of care that are most 
effective in routine care settings and set the basis for further research on the topic.   
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The current literature contains several studies on retention in HIV care, viral 
suppression, models of care, and the successes recorded in using them, but no study had 
compared the outcomes for the various models used in a routine care setting. This chapter 
contains a summary of existing literature on studies related to HIV and use of ART, 
retention in care, viral suppression, use of viral load results in patient management, 
models of care used for C&As, the role of the type of home-based caregiver as well as 
retrospective studies on the topic. The chapter also contains summary information on the 
theory that will ground the research and its appropriateness to the topic.  
Literature Search Strategies 
 For this study, I searched the literature for related studies looking through various 
databases in the Walden University Library and PubMed Central library. The databases 
search included MEDLINE with text, PsycINFO, and CINAHL Plus with text. I also 
search ProQuest to see examples of related dissertations and used Google Scholar to look 
for related articles. Once I found a related article in Google Scholar, I searched for other 
articles that cited that article to identify more recent literature on the topic. In searching, I 
used the Boolean approach and the medical subject headings (MESH) to form and search 
for various combinations of terms such as HIV AND retention AND viral suppression 
AND care model OR model of care AND children OR adolescent OR youth OR orphans. 
The website of the National AIDS Control Committee in Cameroon (NACC), that of 
UNAIDS and CAMPHIA, were also searched to identify current statistics on HIV in 
Cameroon. To find evidence supporting the theory that guided the study, I equally 
searched for social cognitive theory OR SCT in these databases. To access current 
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literature on the topic, I limited the search to publications of the last 5 years except for the 
theory where I did not limit the time due to my interest in seeing papers published from 
the development of the theory. The search in the various databases was also limited to 
articles published in peer-review journals. 
Theoretical foundations 
I selected the SCT to guide the conduct of this research. Albert Bandura first 
articulated this theory in a book titled Social Foundations of Thought and Action 
(Bandura, 1986). As stated by (Mulhollem, 2017), Bandura is considered the most 
influential psychologist of modern times because his theory combines cognitive, 
psychosocial, and behavior processing. This theory holds that personal factors, 
environmental influences, and behavior continually interact in a dynamic three-way 
reciprocal manner (Glanz & Bishop, 2010). The theory has been used to explain the 
judgment of somebody’s behavior concerning his/her personal standards, self-reaction, 
and environmental circumstances. It also holds that social behavior is extensively 
regulated by the exercise of self-influence (Bandura, 1991). Therefore, people should be 
able to make decisions about their own lives, including C&As. It is further broken down 
into five key concepts: learning, triadic reciprocal causation, human agency, self-
regulation, and dysfunctional behavior (Mulhollem, 2017). The human agency concept 
includes self-efficacy and self-regulation, suggesting that external and internal factors 
cause people to regulate their behavior following cognitive processes and environmental 
manipulations (Mulhollem, 2017). Therefore, the SCT builds on the fact that an enabling 
environment and personal factors can influence behavior leading to self-efficacy 
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(Forthofer et al., 2016). This theory further emphasizes learning from the social 
environment in which people may set personal goals, evaluate them over time, get 
motivated by the progress made, and achieve self-efficacy (Schunk & Usher, 2012). 
Various researchers have used SCT to guide studies that explain or predict 
behavior change and health promotion initiatives. For instance, the study of community 
health worker support to improve HIV treatment outcomes for older C&As in Zimbabwe 
was grounded in the SCT with a focus on its concept of self-efficacy, which discussed an 
individual’s ability to act on his or her intentions (Dziva Chikwari et al., 2018). The 
“shape” intervention which utilized the interactive obesity treatment approach (iOTA) in 
a study on the effect of a weight gain prevention intervention on moderate-vigorous 
physical activity among black women in the United States was grounded in the self-
efficacy concept of the SCT (Greaney et al., 2017). Others, such as Duprez, Beeckman, & 
Hecke (2017), used the theory to explain the self-reported performance of supporting 
patients' self-management by final-year nursing students. They found out that the 
students performed poorly and recommended that more attention be given to it in training 
schools (Duprez et al., 2017). These examples highlight how the theory has been used to 
explain social and environmental issues and their influence on various outcomes. 
Appropriateness of the SCT for This Study 
The study had C&As as the study population. They constitute a population that is 
mostly dependent on their parents and caregivers for where they live, what they eat, the 
friends they interact with, and to a great extent, what they know, social protection, and 
the decisions they make (Bröder et al., 2017). They are also fast learners and quickly 
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learn and develop the confidence to perform specific tasks (self-efficacy) when given the 
enabling environment. As explained previously, the HIV clinics used various care models 
to provide services to C&As living with HIV, thus, exposing them to various 
environments. Although the use of CAFCs, for instance, enabled them to play with other 
C&As with the same health condition, the SCVs did not give them such opportunities. 
The specific person who provides care and support for these children at home might also 
influence their behavior and ability to learn and adapt to new regulations, such as 
remembering to take ARVs daily. The involvement of concepts like cognitive learning, 
social environment, interaction, self-efficacy, and adopting new behavior in the research 
made the SCT the most appropriate for use.  
The support provided by parents /caregivers to the C&As at home, the therapeutic 
sessions, play sessions, and enhanced adherence counseling sessions received through 
CAFCs, their interaction with the care providers and their peers might have positively 
influenced their retention in care and viral suppression rates compared with those in 
standard clinics. The opportunities were likely to increase their understanding of the 
importance of staying in care (Bröder et al., 2017) and improve their self-confidence in 
addition to the determination to stay healthy (Forthofer et al., 2016). This assertion was in 
line with the first and second hypotheses, which were accepted or rejected following the 
study findings. The social environment at home varied per child and could be worst for 
children not living with their parents, leading to retention and viral suppression 
challenges. In line with the third hypothesis, it was likely that C&As living with their 
parents would have more favorable conditions that improve their social cognitive 
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behavior and ability to state in HIV care/ achieve viral suppression compared with those 
living with foster parents. Therefore, the research questions were grounded in the SCT, 
which was used to explain the findings obtained.  
Literature Review Related to Key Variables and Concepts 
There is still no cure for HIV, and people living with the virus must be on 
treatment for life, respecting their treatment protocols to achieve viral suppression and 
remain healthy. Retention in HIV care, therefore, is critical for achieving viral 
suppression. It is unclear if the various care models used to provide HIV services to 
C&As in routine care settings are effective, given the continuous poor performance on 
retention in care and viral load results. Also, it is unclear if the outcomes of the C&As in 
care may be affected by the choice of the person who provides care and support for them 
at home. This chapter reviewed the literature to explore findings from other countries 
with similar challenges in their pediatric and adolescent HIV programs. My review was 
guided by the outcome and exposure variables included in the study and mostly limited to 
findings from Africa.  
Overview of HIV and Its Interaction With ART 
HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). When 
someone becomes infected with HIV, the virus affects the body’s defense mechanism. 
The virus gets into the defense cells (T-cells) and replicates rapidly, killing the cells, 
increasing its number, and rendering the person vulnerable to other infections (Cluver et 
al., 2016; Janssen et al., 2014; Kukoyi et al., 2016). ART has proven to be the effective 
treatment which if taken consistently as prescribed can reduce the virus in the body to an 
33 
 
undetectable level (León et al., 2011; Musinguzi et al., 2017; Silver, Dickinson, Seaman, 
& Desrosiers, 2019).  
Previously, the CD4 Count was used for measuring the level of HIV in the blood 
of people living with HIV (PLHIV) to determine if they need to start taking ART 
(Kwarisiima et al., 2017). Various cut-off values were prescribed at different time points 
for PLHIV to start ART until 2015, when the World Health Organization (WHO) 
recommended the "Test and Treat" strategy following scientific evidence from various 
countries, especially Malawi (Dodd, Garnett, & Hallett, 2010; Lima et al., 2015; 
McCreesh et al., 2017; Wagner, Kahn, & Blower, 2011). In the context of "Test and 
Treat", the CD4 count is no longer used to determine if a PLHIV should start ART or not 
but is used for clinical monitoring. There is increased use of viral load measurements to 
assess ART's progress for PLHIV (Kukoyi et al., 2016; Mlisana et al., 2014; Sabin & 
Lundgren, 2013). The third 90 of the UNAIDS 90 90 90 targets states that at least 90% of 
those on ART should achieve viral suppression by 2020 (UNAIDS, 2014).  
So far, there is no cure for HIV infection, but there is the treatment that 
effectively controls and keeps the virus at an undetectable level in the blood (Silver et al., 
2019). There was high HIV attributable mortality and morbidity, especially in SSA some 
years back, due to a lack of effective treatment for those infected (Essajee et al., 2015; 
Granich et al., 2015). The rapid expansion of ART use within the past few years has 
transformed the lives of those living with the virus in the African sub-region. Some ten 
years ago, there was limited availability of ART in Cameroon, and in the few clinics 
where it was present, it was too expensive for most of the population to afford. An HIV 
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diagnosis was thus seen as a death sentence, and there was high morbidity and mortality 
due to HIV. Access to ART increased from 2007 when the Government of Cameroon 
approved the provision of ART free of charge to those in need according to the treatment 
protocols at that time. This increase became rapid from 2013 when the country adopted 
and started promoting the WHO Option B+ strategy to prevent mother to child 
transmission (Muffih et al., 2018). The scale-up became even greater from 2016 when the 
"Test and Treat strategy was adopted in the country. 
Summary of studies related to retention in care 
 Several studies exist in the literature highlighting the importance of retention in 
care and various strategies used in different settings to achieve good retention. While 
retention in HIV care is a major issue in many countries highly affected by the HIV 
pandemic in SSA (Billong et al., 2016; Kiwanuka et al., 2018; Tomori et al., 2013), it 
was a necessary step towards achieving viral suppression (Hall et al., 2017). Retention in 
care helps to improve survival while reducing the chances of transmission of HIV to 
others (Nansseu & Bigna, 2017; Saito et al., 2019; Yehia et al., 2014). Therefore, a 
successful HIV program is that with good retention in care and viral suppression.  
The World Health Organization (WHO) launched the "Test and Treat" strategy in 
2015 to increase access to ART to reduce HIV related mortality following evidence from 
Malawi (Dutta, Barker, & Kallarakal, 2015; Haas et al., 2019; Harries et al., 2016). 
Starting ART early and "Test and Treat" can reduce HIV transmission rates in the 
population (Estill et al., 2018; Nansseu & Bigna, 2017). However, the "Test and Treat" 
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strategy demands improved retention in care as many more people are likely to start ART 
without appropriate preparation (Koirala, Deuba, Nampaisan, Marrone, & Ekström, 
2017). Researchers like Yotebieng et al. (2019), in their consensus statement from the 
International epidemiology Databases to Evaluate AIDS (IeDEA) titled Research 
priorities to inform “Treat All” policy implementation for people living with HIV in sub-
Saharan Africa, state that effective implementation of Test and Treat can end the AIDS 
epidemic. Many counties in SSA have witnessed a rapid increase in ART uptake within 
the last few years, and there is already documented evidence of high attrition within the 
first year of ART initiation (Agolory et al., 2017). Another team of researchers recently 
published their study findings showing that newly identified patients who initiated ART 
within the first 30 days following diagnosis where more likely to be retained in care than 
those who initiated ART after 30 days (Brown Id et al., 2019). The current wide coverage 
of the “Test and Treat” approach in many countries calls for innovative strategies to 
prepare patients adequately prior to treatment initiation and increase the chances for 
retention. 
Documented evidence from the SSA region shows various factors associated with 
retention in care in various sub-populations. A systematic review conducted by Bulsara, 
Wainberg, Newton-john, Centre, & Hills, (2018) using thirty articles found out that 
physical health factors were associated with poor retention in care. In a qualitative study 
by Yehia et al., (2015), participants identified expensive and unreliable transportation, 
stigma, and insufficient insurance as key barriers to retention. Another team of 
researchers also identified transportation cost as a barrier to retention after conducting a 
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survey among 318 patients returning to care after being lost for at least 12 months, 
confirming the finding by Yehia (Gonzalez et al., 2016). Another qualitative study by 
Topp et al. (2018) identified social networks and health system factors as those that 
facilitate or undermine patients' ability to stay in care, which is in line with Bulsara's 
team's findings. Others, like Enane et al., (2018), on their part, identified that certain 
interventions work for adults in improving retention but may not work for children. This 
finding confirms the need for population-specific interventions recommended by 
Kiwanuka and colleagues after a similar study in Pregnant and Breastfeeding Women 
(Kiwanuka et al., 2018). To achieve universal targets for retention in HIV care, various 
program implementers need to use context-specific interventions that are most likely to 
fill the gaps in the given setting. 
Achieving Retention in Care could be more challenging in C&As living with HIV 
than adults. This challenge is because they constitute a vulnerable population (Gray et al., 
2016) as they depend on their parents or other caregivers for shelter, food, clothing, 
education, and other basic needs. A study conducted in South Africa demonstrated that 
family stability was a predictor of low adherence to ART in adolescents. They 
demonstrated that orphans were those most likely to have multiple caregivers, and having 
multiple caregivers was associated with poor adherence (Sher, Norton, Nickell, Biggs, & 
Roux, 2014). A team of researchers from Swaziland confirmed the need for a stable home 
for adolescents who want to belong to stable families, feel accepted, welcomed, and 
appreciated (Shabalala, De Lannoy, Moyer, & Reis, 2016). Unfortunately, many C&As 
on ART do not live in stable homes and are bound to face some of these challenges 
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reported in these studies. However, a study by Gopakumar et al., (2018) on the impact of 
foster homes on the Health-Related Quality of Life (HRQOL) for C&As living with HIV 
in the foster homes compare to stable homes found no statistically significant difference 
between the two. While this result provides hope for the children living with foster 
parents in other settings, the findings' generalization may be questionable, calling for 
further research in that domain.  
Several studies conducted in Cameroon to measure retention in HIV care recorded 
retention rates of less than 90% at 12 months. In a study that collected data from 56 
health facilities in all ten Cameroon regions, the 12 months retention rate was 60.4% and 
was calculated for 5,005 patients, including adult men, women, and children. The 
treatment centers in reference hospitals had lower retention rates compared to smaller 
HIV management units (54.2% vs. 66.8%), p < .0001; males had lower rates compared to 
females (57.1% vs. 62.0%), p = .007; and there was no significant difference in retention 
rates between adults and children (Billong et al., 2016a).  
The 12 months retention in care was 79% in a prospective cohort of 669 PBFW 
enrolled on PMTCT Option B+ at 22 purposefully selected health facilities in two 
regions, the Northwest and Southwest (Muffih et al., 2018). A similar study focusing on 
PMTCT women completion of the HIV cascade found out that only 355 (36.4%) of the 
976 HIV-infected women enrolled completed the PMTCT cascade (Dionne-odom et al., 
2016). The findings also show two exposure variables associated with PMTCT cascade 
completion, which were; awareness of partner HIV status (aOR 1.4, 95% CI 1.01–2.0) 
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and receiving an HIV diagnosis before pregnancy compared with HIV diagnosis during 
or after pregnancy (aOR 14.1, 95% CI 5.2–38.6). This finding emphasizes the importance 
of partner/family support to those on ART, consistent with what was reported by 
Shabalala et al., 2016. Another PMTCT study of 12-month retention in care for 268 
PBFW on Option B+ in five sites in the Kumba Health district found an 81.1% retention 
rate (Atanga et al., 2017). The researchers went further to document high staff turnover as 
the main reason for discontinuation [aOR 2.5 (95% CI 1.6, 3.9), P < .001]. The main 
reasons for stopping treatment included status denial, religious reasons, and lack of 
transport fare to go for medication pickup (Atanga et al., 2017).  
The published literature on pediatric and adolescent HIV care in Cameroon has 
little on their retention in care or viral suppression. A study on malnutrition conducted at 
the Laquintinie Hospital in Douala identified an urgent need to detect and treat 
malnutrition in children below five years enrolled on ART. The prevalence of 
malnutrition in the sample of 217 children under 5 was 68.7%, with 42.4% of them in the 
severe or advanced immunological stages of HIV, according to WHO (Penda, Moukoko, 
Nolla, Evindi, & Ndombo, 2018). Children in the severe and advanced WHO stages are 
likely to develop treatment failure and eventually die (Tchouwa et al., 2018). However, 
another study conducted in Yaounde to measure predictors of mortality in children who 
had been on ART (2005 – 2009) found out that the probability of survival after four years 
of treatment was 88.7% (95% CI = [84.2–93.3]) with the WHO clinical stages III and IV 
(HR: 3.55 [1.09–13.6] and HR: 7.7 [3.07–31.2]) independently associated with death 
(Njom Nlend & Loussikila, 2017). A similar study by Prof. Nlend to measure the 
39 
 
outcomes of protease inhibitor-based ART in children and associated-factors found out 
that all the 71 children (5-12 years) enrolled and who had been on ART for a mean 
duration of 7 years experienced clinical success in their therapeutic responses with a 
74.7% viral suppression rate (Nlend et al., 2019). Programmatic data from national 
reports show lower viral suppression rates in C&As. The study generated findings from 
various sites implementing routine care practices that will contribute to the existing 
literature in this domain.  
Summary of studies related to viral suppression 
HIV Care providers previously used the CD4 count to determine when it was 
appropriate for someone diagnosed with HIV to start ART and used it to monitor their 
progress on ART. Since 2013, WHO recommended using viral load to monitor patients 
on ART, but the coverage remained limited in Low and Middle-Income Countries like 
Cameroon (Peter et al., 2017). Viral Load values indicate whether the person on ART is 
thriving well or if there is treatment failure that needs a revision of the treatment plan. 
With limited coverage of viral load, as is the case in many countries, it becomes 
challenging to assess progress on the third 90, viral suppression (Peter et al., 2017). 
Therefore, there is an urgent need to scale up viral load coverage in HIV endemic 
countries and improve on the use of the results in patient management to improve 
outcomes. 
Several studies have documented inadequate viral load coverage in developing 
countries, especially those in SSA. The WHO and other international recommendations 
for using viral load to monitor ART patients have not been directly translated into local 
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policies and actions (Killingo, Taro, & Mosime, 2017). Even with policies in place, there 
is a need for a supportive environment for their implementation and demand creation 
through mobilization, training HCWs on sample collection, transportation, and return of 
results. As documented by Killingo et al., (2017), there is a need for the use of demand 
creation models to achieve the 90 90 90 goals by 2020, and routine viral load monitoring 
becomes more relevant now than ever before. The possibility of using point of care 
machines for viral load testing further increases access to testing services (Kulkarni et al., 
2017). Program implementers could draw experiences from the scaling up of EID 
services for HEIs and CD4 count measurement using POC machines, which are two 
interventions rapidly scaled-up in previous years to scale up viral load coverage (Peter et 
al., 2017).  
Viral load coverage is even lower in C&As who need closer monitoring and 
adjustment of doses or regimen switching based on their outcomes (Ferrand et al., 2017). 
An international cohort collaboration recently published an article in the Lancet that 
documents high rates of missed opportunities in switching children to second-line ART 
due to poor monitoring strategies (Collins et al., 2019). Their study had a large sample 
size (93,351 participants) and included data from several countries, with 90% of SSA 
participants. They found out that health care providers use various strategies for 
monitoring children on ART, including the use of CD4 counts, viral load, and clinical 
monitoring. The cumulative incidence of switching to a better therapy when indicated 
varied from 6.8% (6.5-7.2) in settings where CD4 or viral load were used to 0.8% (0.6 -
1.0) in settings where only clinical monitoring was used (Collins et al., 2019). This 
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finding highlights the alarming number of missed opportunities occurring in settings 
where children on ART go for years without any CD4 or VL test done. A study from 
Cameroon has documented improved viral suppression rates for children enrolled on 
Protease inhibitor-based ART (Nlend et al., 2019), which could become an option to 
switch to if the outcomes for other regimens are not as expected. Another study carried 
out in the Eastern Cape region of South Africa highlighted the need for greater 
monitoring of children to avoid viral rebound even after viral suppression has been 
achieved. The researchers followed-up children from 0-12 years for 24 months through 
quarterly visits and noticed increasing viral suppression rates over time [at six, twelve, 
and twenty-four months were 57.6% (95% CI 52.1 to 62.7), 78.7% (95% CI 73.7 to 82.9) 
and 84.0% (95% CI 78.9 to 87.9) respectively]. However, they also found out that 
younger children <12 months had a twofold increased risk of viral rebound compared 
with six to twelve-year-old (Teasdale et al., 2018). A similar study from Ghana 
highlighted the urgent need for increased viral load monitoring (Kukoyi et al., 2016). 
Programmatic data from Cameroon confirm this need, especially in rural areas. 
C&As also have an increased risk of having poor treatment outcomes associated 
with where they receive care. A cross-sectional study conducted in Cambodia in 
adolescents 15-17 years old found the likelihood of having viral non-suppression was 
higher in adolescents receiving ART in an adult clinic (Chhim et al., 2018). The 
researchers recommended implementing interventions that promote psychosocial support 
and treatment literacy, which have been implemented in Cameroon. Another study 
focusing on the decentralization of pediatric care services identified the transfer from one 
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facility to another or the community as a particularly vulnerable step in the pediatric and 
adolescent treatment cascade (Teasdale et al., 2017). Teasdale and her colleagues (2017) 
reviewed medical records in a high-volume clinic (Dora Nginza Hospital in Port 
Elizabeth, South Africa) for all children 0-15 initiated on ART between January 2004 to 
September 2015 and identified all those transferred out following the decentralization of 
ART. They followed up in 16 outlying clinics where the children were transferred and 
carried out community tracing for children who were not in care in the facility they were 
transferred. They found out that of the 644 children transferred to the 16 sites, 211 
(32.8%) had an unsuccessful transfer (Teasdale et al., 2017). An unsuccessful transfer 
indicates that the child stopped treatment with increased chances of viral load rebound 
and the likelihood of mortality. Not many programs have gone out of the regular clinic 
visits to follow up those not regular in care, as was done in this study. The need to 
improve the follow-up for children and improve reporting on their virologic outcomes is 
critical (Ferrand et al., 2016), given the overall low performance on the outcomes 
(retention & viral suppression). 
Pediatric ART services in Cameroon were previously limited to few big hospitals in 
the big cities and other clinics that identified an HIV positive child referred to these large 
clinics for evaluation and possible ART initiation (Njom Nlend & Loussikila, 2017). 
Given the transportation challenges and related costs involved in covering long distances 
to the cities for regular care, it was apparent that the retention in care and viral 
suppression rates for such children linked from long distances will be low. The study by 
Billong et al. (2016b) found out that children had lower retention rates than adults, and 
43 
 
the other study by Tchouwa et al. (2018) recorded lower viral suppression rates for 
children in big reference hospitals in Cameroon. While the big hospitals have higher 
quality medical teams and equipment needed to monitor the C&As, personal factors, 
distance, and cost limit the hospitals' visits, leading to these poor results.   
The use of viral load results for patient management 
With sub-optimal coverage of viral load testing in C&As in Cameroon, there is also 
limited capacity among care providers on its used for patient management. Patients with 
high viral load require close follow-up and possibly a change of regimen for improved 
outcomes. A cross-sectional study carried out in 12 health facilities across seven of 
Cameroon's ten regions documented the low capacity of health care workers in initiating 
and managing children on ART and their limited knowledge on the content of national 
standard protocols (Penda et al., 2019). Another Cameroonian study also documented low 
viral load uptake in adults, with only 54% of those with high viral load switched to a 
second-line regimen (Awungafac et al., 2018). Therefore, while efforts are made to 
increase the uptake of viral load, using viral load results in managing the patients for 
improved outcomes is even more critical. 
Models of Care implemented to improve retention in care and viral suppression  
Existing literature has several best practices used in studies in various SSA 
countries to improve treatment outcomes for C&As. While some of the researchers 
evaluated outcomes in terms of retention in care, others measured viral suppression rates 
or both. The findings generally highlighted the importance of using differentiated care 
44 
 
models to tailor the services provided to the needs of the patients. They used Randomized 
Control Trials (RCTs), mixed methods, surveys, and qualitative approaches to study and 
document their findings. RCTs included the study that highlights the impact of a family 
clinic day in Uganda (Graves et al., 2018), the importance of the streamlined care model 
in East Africa (Brown et al., 2016), the use of community-based interventions in 
Zimbabwe (Mavhu et al., 2017) and a community demand creation model (Killingo et al., 
2017). Other researchers used the prospective cohort monitoring approach, including the 
study in Uganda and Kenya that highlights the importance of streamlined care models to 
reduce structural barriers (Kwarisiima, Jain, Ruel, & Clark, 2017) and from South Africa 
on the importance of adherence clubs (Tsondai et al., 2017). Another team of researchers 
used the mixed methods approach to study the effect of patient-centered approaches such 
as multi-month dispensation, fast-track drug refills, community ART groups, and other 
strategies to improve individual patient outcomes (Prust et al., 2017). Lettow et al. 
(2014), on their part, used a Survey approach to highlight the importance of differentiated 
models of care in PMTCT clients, while MacCarthy, Mendoza-Graf, Huang, Mukasa, & 
Linnemayr (2019) used a qualitative approach to point to the importance of patients 
setting personal targets for their treatment outcomes. These encouraging results from 
research studies provide hope for the achievement of the third 90, although the 
generalizability of some of the findings is questionable.  
Research findings with specific samples of the population may hardly reflect the 
situation in routine health care settings. A recent study by Mathew Fox and others 
showcased the importance of adherence clubs and decentralized care in improving viral 
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suppression rates and sustaining the suppressed status over a one-year follow-up period in 
South Africa (Fox et al., 2019). Another study documented the improved viral 
suppression rates following an intense adherence counseling program for C&As in 
Uganda (Nasuuna et al., 2018). On the other hand, an evaluation of the national HIV 
program in Nigeria showed low retention and viral suppression despite the many 
interventions by the government and various inputs from international partners (Dalhatu 
et al., 2016). Similarly, the findings from the Cameroon population-based HIV impact 
survey of 2017 showed an 80.1% viral suppression rate with low viral load coverage 
(CAMPHIA, 2018). While some of these impressive interventions that have generated 
significant results in the different studies may not yield the desired results in routine 
settings, the resources required to implement them may also be a limitation to a national 
scale-up plan. Besides, the estimated resource requirements for ART programs working 
towards the 90 90 90 targets and implementing the test and treat strategy are enormous 
(Dutta et al., 2015). There is a need to identify cost-effective strategies that could be 
scaled up with minimum resources (Barker, Dutta, & Klein, 2017). The study has 
generated evidence for the most effective current use approaches, which could be 
implemented at scale in Cameroon.  
The role of family status or the caregiver on treatment outcomes 
Apart from the clinical care and medications provided through the clinics, C&As 
need enormous support from the family to stay on ART and achieve viral suppression. 
This care is provided by their parents or other family members. Few researchers have 
studied the contribution that the child's family status or type of caregiver at home may 
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play on C&As' treatment outcomes on ART. Two studies from Uganda, South Africa, 
and Malawi document HIV's burden on child development and health outcomes. Sherr, 
Skeen, Hensels, Tomlinson, and Macedo (2016) found out that HIV positive parents 
suffered from depression, which affected their children's development. Caring for an HIV 
positive child could also lead to depression, which will affect even the child's care. 
Another group of researchers found evidence that home-based care for children living 
with HIV was burdensome and should not be left in the hands of caregivers alone (Osafo, 
Knizek, Mugisha, & Kinyanda, 2017). Gray et al. (2016) presented evidence that orphans 
were more likely to have traumatic experiences that lead them to risky reproductive 
health practices, which could be worst for those on ART. Another team in South Africa 
documented multiple caregivers' effect on retention and viral suppression but identified 
that orphanhood was not associated with viral suppression (Sher et al., 2014). 
Orphanhood was not associated with death in children on ART according to findings 
from a Cameroonian study (Nlend et al., 2019). A similar study from India found no 
association between living in foster homes and quality of life plus the risk of HIV 
infections (Gopakumar et al., 2018). With this limited and contradictory existing 
evidence on the association of family/caregiver to treatment outcomes in C&As on ART, 
further research is needed to provide more guidance on the topic. These findings justified 
the inclusion of the third research question in this study. 
Summary of studies that used a retrospective cohort monitoring approach 
  With limited resources and time available for research on retention in care and 
viral load status requiring long-term follow-up, it is easier to use retrospective studies to 
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examine from the outcomes backward and study the exposures that may explain the 
variability in the outcome. The study that evaluated the national HIV program in Nigeria 
used the retrospective approach (Dalhatu et al., 2016). These authors analyzed cohort 
data extracted from medical records for a nationally representative sample of 3,496 
patients >15 years old recruited on ART from 2004 – 2012. Three other related studies 
that used the same methodology include; A study conducted in Swaziland which 
documented 12.5% retention at 12 months of 32 children <18 months recruited and 
followed up through routine child welfare clinics (Sikhondze & Mahomed, 2017); a study 
of retention in injection drug users on ART in Vietnam who were also taking methadone 
therapy (Pham et al., 2017), and the study conducted to identify early warning indicators 
of HIV drug resistance in Cameroon in 2010 (Billong et al., 2012).  
The advantage of using the retrospective cohort monitoring approach in these studies 
is seen in the time taken to conduct them and the resources required. The researchers 
were able to generate evidence from the interventions without waiting for long-term 
follow-up to establish outcomes. They were also easy to conduct and did not have the 
objective of establishing a causal relationship. Researchers seeking to prove a causal 
relationship cannot use a retrospective cohort approach but will instead carry out 
randomized control trials or prospective cohort monitoring approaches or other 
complicated study designs. I had limited time to complete my research and complete my 
dissertation. My objective was to establish if there is an association between care models 
and type of home-based caregivers on the retention in care and viral suppression status of 
C&As on ART. It was a simple study to be completed quickly, and the retrospective 
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cohort approach was sufficient for answering the research questions. The variables and 
covariates included were those available in the existing medical records and enough to 
respond to the research questions.  
Summary of the chapter 
Summarily, much evidence exists on the importance of retention in HIV care, 
retention challenges, interventions that have proven effective in particular settings, 
differentiated models of care, the urgent need for scaling up viral load coverage, use of 
viral load results, and limited studies on the relationship between the type of home-based 
care provider and treatment outcomes for C&As. There are few studies focused on 
treatment interventions to improve outcomes in children compared to the several adult-
targeted interventions. Few studies included viral load/viral suppression in C&As in 
Cameroon as an indicator, and none that focused on it specifically. The study conducted 
in the National Social Insurance Fund hospital looked at orphanhood as a predictor of 
death which could relate to viral non-suppression (Njom Nlend & Loussikila, 2017), but 
did not look at the person who provides support to the orphan or non-orphan and to see if 
it is also associated to mortality. Therefore, this study is the first to document retention 
and viral suppression by care models used for C&As in Cameroon and is the first to 
document if there is an association between the type of caregiver at home and the 
outcomes. Findings from the study will also create the basis for further studies. For 
instance, a tracing campaign to search for and bring back children lost to follow-up and 
interview their caregivers to document reasons for drop out could be a likely next step 
after this study. Other researchers may also be interested in conducting the same study 
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prospectively while monitoring the clinical and psychosocial services provided to see if 
they may obtain similar results.  
Conclusion 
I reviewed and summarized the literature on retention and viral suppression for C&As 
living with HIV and their association to models of care used and family status or type of 
caregiver who supports them at home. The lack of any publication comparing treatment 
outcomes in various models of care used in routine care settings and lack of any study 
that looked at the association between the outcomes and the person who provides care to 
the C&As at home indicated the pressing need for my study. I used a retrospective cohort 
monitoring approach to review, analyze and share findings from Cameroon on the topic. 






Chapter 3: Research Method 
Introduction 
The purpose of this study was to compare the 12 months’ retention in care and viral 
suppression rates for C&As enrolled on ART in Cameroon by the care models used to 
manage them to identify the model with the best outcomes for possible scale-up. The 
study also assessed if there are significant associations between the type of the home-
based care provider and viral suppression and the type of home-based care provider and 
consistency of medication pickup in C&As on ART in Cameroon. The study’s primary 
outcomes were retention in care at 12 months, viral load status, which is often classified 
as suppressed or not suppressed based on the value, and the proportion of consistency in 
medication pickup. The exposure variables were the care models used and the type of the 
home-based caregiver. Possible confounders included in the study were age and sex. In 
this study, I sought to identify the best HIV care model among the three used and the type 
of home-based caregiver associated with better outcomes in routine health care settings in 
Cameroon for C&As, which could fill an existing gap in the literature. The findings could 
also inform program planning, funding prioritization, family counseling practices, and 
national program scale-up strategies that promote specific high-impact interventions. 
In Chapter 3, I will describe the research design, methodology, study population, 
participant selection, and operationalization of variables, data collection, cleaning, 
analysis, and interpretation of results, threats to the validity of results, ethical 
considerations, and IRB requirements. I conclude the chapter by connecting to this plan’s 
operationalization, whose findings I describe in Chapter 4.   
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Research Design and Rationale 
 I used a quantitative method of inquiry with a retrospective cohort review 
approach to collect and analyze existing data from medical records in the ART clinics on 
C&As (0-19 years old) who were current on ART in Cameroon from January 2018 to 
December 2019. Retention in care and viral suppression are achieved over time. 
Therefore, studying them using a retrospective cohort review approach saved time. 
Because monitoring interventions prospectively takes a long time, more resources, and a 
lot of effort, it was easier to collect information from existing medical records for this 
research, cognizance of the approach's limitations. Further, I looked for associations 
between the outcomes and exposure variables and not for some causal relationships. A 
retrospective cohort approach was appropriate for a quick study like this one whose 
findings were needed soon and could prompt intervention studies that monitor a 
particular aspect of care over time. 
 The study variables included the viral load status and retention rate at 12 months as 
the primary outcome variables. The exposure variables include the models of care, the 
family status or type of home-based caregiver, and two covariates: age and sex. The 
outcome variables had quantitative measures classified into categories to ease analysis, 
justifying the use of a quantitative research methodology. Viral load testing, according to 
the national protocol, is done 6 months after ART initiation. In this study, I planned to 
assess the 12 months’ retention in care for the study participants, the consistency of their 
medication pickup, and the viral load results. An intervention study with randomization 
and prospective participant recruitment and monitoring over time would have been the 
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best method of inquiry to establish causal effects. I decided to use a retrospective cohort 
study approach in this case given the amount of time and resources required for 
intervention studies, the convenience of using existing data, and my objective of looking 
for associations and not causal relationships. However, my design was robust, and the 
large sample size recruited from five of the 10 regions of the country, which represented 
about 70% of the HIV burden, strengthened the generalizability of the findings. 
Target Population 
 The study population included all C&As aged 0 to 19 years old, living in 
Cameroon. These included males and females, those schooling and those not schooling, 
those living with their biological parents, and those living with foster parents. Cameroon 
currently has a total population of approximately 24 million people, with approximately 
5% being C&As ages 0 to 19 years. The C&As included those living with HIV, which 
they might have acquired from their mothers while still in the womb, delivery, or other 
sources after birth. National estimates indicated that approximately 4,100 children 
acquired HIV in 2015, and only approximately 30% of those living with HIV and on 
ART had a viral load test done (Rao et al., 2019). This study focused on the C&As living 
with HIV and enrolled on ART in 27 clinics in five of the 10 regions. Being a 
retrospective cohort study, the review of records and data collection focused only on the 
period from January 2018 to December 2019.  
Sampling and Sampling Procedures 
The selection of regions and clinics for the study followed a convenient sampling 
procedure. I used purposeful sampling to select the regions because the various HIV care 
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models were implemented only in some sites in these regions. The Northwest, West, 
Center, Littoral, and Southwest regional programs used child and adolescent friendly 
clinics in some clinics and support groups in others. The West regional program used 
only support groups and standard clinic visits in all their clinics. These regions were also 
more accessible in terms of the distance to cover to sites and obtaining administrative 
approval to collect data was more straightforward than the other five regions. Site 
selection from the five regions was purposeful to ensure that the sample chosen included 
a reasonable number of children in each care model. I sought a representative population 
living in urban versus rural areas and these five regions have over half of the total number 
of people living with HIV in the country. Achieving a good rural/urban mix of 
participants required many more sites in rural areas because most big pediatric ART sites 
were in the cities where just one clinic could have the necessary number of participants 
for a model. Therefore, more sites were purposefully added from the rural areas. In the 
various selected clinics, C&As were included if they met the participant inclusion 
criteria. 
Participant Inclusion and Exclusion Criteria  
 The study sample included only C&As 0 to 19 years old, males and females living 
with HIV, and who were on ART for 12 months (between January 2018 and December 
2019) in the selected sites. This sample included those who were already on ART before 
starting the period and those who initiated ART during the period and attained 12 months 
on treatment before December 2019. I excluded those who started ART within this period 
but were not on it for up to 12 months because retention in care was assessed for 12 
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months. Also, participants included were only those who had at least one viral load test 
done and documented within the 12 months. I did not include those on ART within this 
period but did not do a viral load test because the viral load status was the primary study 
outcome. This exclusion criterion justified why many sites were included to meet the 
desired sample size for care models. 
Sample Size Calculation 
 This study’s objective was to examine the associations between two independent 
variables that were categorical and two dependent variables, one of which was 
continuous. The independent variables were models of care divided into three categories, 
and the type of home-based caregiver was also divided into three groups. The models of 
care were child and adolescent-friendly clinics, support groups, and standard clinic visits. 
The type of home-based caregivers included both parents, one parent (mother or father), 
and foster parents (aunt, uncle, sister, brother, others). For the dependent variables, viral 
load status was measured in the number of copies per milliliter of blood and classified 
into two categories based on the values. I coded this variable into a dichotomous variable 
with values less than 1000 as “suppressed” and values more than 1000 as 
“unsuppressed.” Retention in care is another dependent variable that was assessed and 
was measured by the proportion of C&As on ART or enrolled within the study period 
who remain in care after 12 months. The consistency of medication pickup was also 
assessed for each client within the last 12 months. The proportion of months on ART (as 
documented in the registers) was calculated and recorded for each client. For this study, I 
included age and sex as covariates. Sex was a dichotomous categorical variable, and 
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participants were either males or females. The C&As were managed in four groups at the 
clinics for age-adapted therapeutic education. These groups included children ages 0 to 4 
years, those 5 to 9 years, 10 to 14 years, and adolescents 15 to 19 years. This study 
classified them into two groups with those aged 0 to 14 years seen as children and those 
aged 15 to 19 years as adolescents. I used the logistic regression as the statistical analysis 
method to determine the predictive association between the dependent and independent 
variables. I ran a binary and multiple logistic regression analysis to test the study 
hypothesis. I also used ANOVA to check for an association between the consistency in 
medication pickup and type of caregiver. I interpreted the findings using an alpha equal 
to or less than .05 as significant. 
  Using G*Power, version 3.1.9.2 (Faul, Erdfelder, Lang, & Buchner, 2007), I 
estimated the study’s sample size while making certain assumptions (American Statistical 
Association, 2017). I assumed an alpha of .05, a 95% power, a two-tailed test, and an 
effect size (Odds ratio) of 1.3, which gave me a minimum sample size of 1,188. Reducing 
the study’s power to 80%, which is the minimum power required to have reliable results 
(Meyvis & Osselaer, 2018), gave me a minimum sample size of 721. I planned to use the 
sample size that provides the maximum power to the study results, which was the 1,188 
participants. The effect size of 1.3 was the minimum required to determine a predictive 
relationship between the dependent and independent variables. Being a retrospective 
cohort study, I included all eligible participants in the selected study sites as it was 
feasible to have the largest sample size. Having a large sample size would generate more 
representative results of the population’s real situation (Meyvis & Osselaer, 2018). Given 
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the low uptake of viral load testing in C&As in Cameroon (CAMPHIA, 2018), I had to 
visit many more sites to obtain at least a minimum of 1,188 participants to maintain the 
power of 95% and an effect size of 1.3.  
Procedures for Participant Recruitment and Data Collection in the HIV program 
  The national protocol in Cameroon requires that once somebody tests HIV positive, 
they should receive counseling and encouragement to start ART on the day of diagnosis 
or within one month. A positive HIV test result is, therefore, the main inclusion criteria 
for ART initiation. People who test HIV positive and are not willing to start treatment 
immediately, are too sick to take medications or are on treatment for Tuberculosis are 
excluded until they become ready to start ART according to the national protocol. Once 
initiated on ART, demographic information on several indicators like age, sex, location, 
parent's HIV status is collected and documented in the national registers. Baseline 
information, including results of various tests conducted and treatment regimen, are also 
recorded in the registers. A medical file is opened for each patient, containing the 
demographic information and additional personal and clinical information about the 
patient. Patients give their consent to start ART. Those who refuse to begin ART receive 
ongoing counseling support and eventually decide to start, but nobody is forced to start 
ART. After ART initiation, service providers document necessary information for each 
clinical visit in the two records (registers and files), facilitating patient follow-up. These 
patients are expected to stay on ART for life, except researchers eventually find a cure for 
HIV. However, some participants drop off with time due to various reasons that lead to 
poor retention in care for specifically C&As. Service providers used various strategies to 
57 
 
achieve full retention in care, including differentiated care models tailored to the needs of 
the individual patients and monthly patient tracking and bring back-to-care campaigns. 
The data in the medical records has evidence for retention since each visit is documented. 
The various clinical monitoring exams done, such as the viral load test, are also noted in 
these tools.  
Participant selection and data collection  
 I used participant data already existing in registers and medical files in the hospitals 
for the study. As described under the target popultion, I selected 27 study sites in the five 
regions based on the model of care implemented. At the sites, participant selection was 
limited to those current on ART during the study period who had been on ART for at 
least 12 months and had at least one viral load test result documented in the records. 
These registers and medical files are the most reliable source documents for routine HIV 
services in all sites. Therefore, their use is inevitable in the conduct of retrospective 
studies like this one.  
 In each site, I used the registers to identify the appropriate cohort of patients 
selected for the study. With the help of the site leader or the nurse in charge of the 
pediatric cohort, we retrieved their medical files. The use of the registers and medical 
files concurrently was inevitable since information completion in the tools was usually a 
challenge and using the two provided complete information. I then reviewed information 
on their viral load results from the registers and files and identified all those with a 
documented viral load result in the last 12 months. These were the participants whose 
information was collected, ensuring not to record identifiers like names or phone 
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numbers. The collected data were recorded on a data abstraction form, which was the 
only document I took away from the clinic. I excluded eligible patients with no complete 
information from the study after reviewing both the registers and medical files. 
  Before data collection, I obtained IRB approval from the National Ethics 
Committee, the Cameroon Baptist Convention Health Board IRB, and from the Walden 
University to conduct the study. I met with key stakeholders and leaders of all the 27 
facilities involved in the study who provided administrative letters of approval for me to 
collect the data from their facilities. With all the approvals, I did not have any challenges 
in gaining access to data collection records. 
Instrumentation and operationalization of constructs  
I developed and used a data abstraction form, which I printed out in hard copy and 
used to record information on the variables of interest upon reviewing registers and 
medical records onsite. Since this was a retrospective study using secondary data, I 
ensured that all the variables I needed to analyze to answer the four research questions 
were included. To ascertain this, I did a pilot collection in one site, reviewed and 
analyzed the data to be sure that it had all my required variables, and made adjustments if 
any was lacking before conducting full data collection. I decided to use a hard copy data 
collection form because it was more feasible in sites without electrical power to charge 
computers. Besides, putting the information on hard copies to later enter the spreadsheet 
on the computer enabled sorting and correction of any errors, increasing the data's 
accuracy. The hard and soft copies carried participant codes with no identifiable 
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information. I entered the data into the soft copy of the excel form in the computer and 
later transferred it into SPSS version 25 for analysis. I explored and analyzed the data as I 
collected from one site to another, which was the advantage of collecting it personally. I, 
however, used two trained research assistances to collect data from a few far-off sites. 
The research questions were set based on the data available in the medical records. Other 
information that could be useful, but which did not exist in the medical records, was 
excluded from the study design. The data abstraction form, therefore, contained all 
information needed to answer the research questions.  
Operationalization of variables 
Viral Load status – primary outcome variable. The viral load status is used to 
assess ART treatment success in Cameroon, just like in other countries fighting the HIV 
epidemic. Blood samples are tested in the laboratory, and viral load results are obtained 
and presented in terms of the number of copies per milliliter of blood used. The number 
of copies recorded for each patient are usually classified into two main categories; virally 
suppressed for patients with viral load results less than 1000 copies/ml and virally 
unsuppressed for patients results indicating > 1000 copies/ml (Awungafac et al., 2018). 
The global UNAIDS goal for HIV programs was for every country to achieve 90% viral 
suppression in all those on ART by 2020 (Jamieson & Kellerman, 2016). The analysis of 
the patients' viral load status included in the study generated findings on their suppression 
rates, which showed at what percentage Cameroon is with the third UNAIDS goal in the 
study population and which model of care provided the lowest VL copies/ml.  
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Retention in Care. In HIV programs, retention in care refers to the number of 
patients still in care after a specified period (three months, six months, 12 months, or 36 
months) following their ART initiation. In assessing retention rates, cohorts of patients 
who started ART within a given period are tracked to see how many of them remain in 
care over time. The number of those still in care compared to the number that started 
provides the retention with rates per site. In this study, retention was a categorical 
variable recorded as "retained" for those who were still in care after 12 months or "not 
retained" for those who dropped off either through death, transfer to other sites, or were 
lost-to-follow-up. Retention in care is almost an indispensable pre-requisite to viral 
suppression since patients need to stay in care and adhere to therapy to achieve viral 
suppression (Tsondai et al., 2017). For this study's purpose, I assessed retention in care 
for all study participants by checking their treatment status after 12 months or 12 months 
following initiation for those who started ART after Dec 2017 to note those still in care. 
This enabled me to record the proportion retained and calculate the retention rate by care 
model and region. 
 Consistency of medication pickup. For each participant, I calculated the 
proportion of months they were regular on ART during the 12 months as documented in 
the registers. The C&As who were on ART for all 12 months scored a 100% while those 
who missed medications for two months for instance had a proportion of 83% calculated 
by dividing the number of months on medication (10 months) by 12 months and 
multiplying by 100. During data collection, we counted and recorded the number of 
months on ART with the 12 months’ period following the documentation in registers. 
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The calculation of the proportions was done after data entry and analyzing this data by 
type of care provider enabled me to answer the fourth research question.  
Care Models.  This study included three specific care models used to manage 
C&As in Cameroon. Some C&A attended just the Standard Clinic Visits (SCVs) and 
picked up their medications in addition to consulting a clinician if needed. Some clinics 
had organized group meetings and gave appointment dates to the C&As to visit the 
clinics on a specific convenient day, such as Wednesday afternoons or Saturdays when 
those schooling had no classes. These group sessions, also called Support Groups (SGs), 
provided an opportunity and time for the children to play together, sing, dance, receive 
health information, and pick their medications. These sessions held in a venue most 
appropriate to the health care providers based on the infrastructure available onsite. In the 
third option, health facilities, with external partners' financial support, renovated and 
equipped specific spaces within the facilities to serve as Children and Adolescent 
Friendly Corners (CAFCs), where the children met in age-adapted groups. Apart from 
playing and interacting with their peers, the service providers used a well-structured 
curriculum to give the C&A information adapted to their age on health, personal hygiene, 
HIV/AIDS, disclosure of HIV status, and reproductive health. In these groups, service 
providers ensured that C&As received both clinical and psychosocial care services during 
group activities. In sites where the SGs and CAFCs existed, C&A newly enrolled on 
ART were encouraged to join the group sessions. The participant enrolled in each model 
was based on the model's availability in the site where they received care. Participants in 
sites without CAFCS or SGs had no option but to belong in the SCVs care model. For 
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this study, I classified the participants into three groups based on their care model and 
coded the data for analysis. 
The type of home-based caregiver. There was information available onsite on 
the caregiver for each of the C&As enrolled on ART and their HIV status. For this study's 
purpose, I named this variable as the type of home-based caregiver, which refers to the 
person available at home to support the C&A in their treatment process. I classified the 
information into three main categories; both biological parents, a single parent (mother or 
father), and foster parents who could be aunt, uncle, sister, brother, or others. I extracted 
information on each patient's caregiver and classified each of them in one of the three 
groups coded as P1, P2, and P3 for data analysis.  
Age. Age is also written as an indicator on its own in the medical records but is 
hardly updated. I calculated each patient's age based on their date of birth, which was 
included in the medical records because the age in the records could be the age at the 
time it was documented and not the current age. I rounded up months greater than or less 
than six to the nearest whole number during age calculation. For example, I considered a 
child who was five years, eight months as a 6-years-old child, while taking one who was 
is three years, four months as a three-year-old child. For this study, I classified the age 
values into two dichotomous categories: ages 0 -14 years as children and those 15-19 
years as adolescents.   
Sex. I classified each participant in the study into two dichotomous categories as 
male or female in line with the normal population distribution in Cameroon. This 
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information was copied from the medical records, documented onto the data abstraction 
form, and coded for analysis.  
Data entry, coding, cleaning, and data analysis plan 
Data entry, cleaning, and coding. As soon as I completed data collection for 
each site, I entered the data into an excel spreadsheet, a replica of the data abstraction 
form. I reviewed the data for consistency and corrected any entry errors that I identified. I 
crosschecked the entries again a few days after entry, matching the data abstraction forms 
to that in the computer to ensure data completeness and accuracy. Once I finished with all 
the data collection and entry, I use bar charts and histograms in excel to see the 
distribution of data for various variables pictorially and identify possible outliers. I 
created a codebook for the categorical variables in excel, which was required to interpret 
findings. I then exported the data into SPSS (v. 25) for analysis and reported both 
descriptive and inferential statistics plus their interpretations. Once the data was in SPSS, 
I recoded the continuous variables as appropriate for data analysis. I carried out data 
exploration by running means, medians, and standard deviations to identify and verify 
any outliers in the data for the continuous variables. I used frequency tables to examine 
the distribution of categorical variables and did any further data cleaning that could be 
required before the actual analysis.  
A restatement of the research questions and hypothesis 
Research question 1(RQ1). Is there an association between the 12 months’ retention in 
HIV care and the HIV care model used for C&As after controlling for age and sex?  
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Null Hypothesis (Ho1): There is no significant association between the 12 months’ 
retention in HIV care and the HIV care model used for C&As on ART after controlling 
for age and sex. 
Research Hypothesis (Ha1): There is a significant association between the 12 months’ 
retention in HIV care and the HIV care model used for C&As on ART after controlling 
for age and sex.   
Research question 2 (RQ2). Is there an association between viral suppression and the 
HIV Care model used for C&As after controlling for age and sex?  
Null Hypothesis (Ho2): There is no significant association between viral suppression and 
the HIV care model used for C&As after controlling for age and sex. 
Research Hypothesis (Ha2): There is a significant association between viral suppression 
and the HIV care model used for C&As on ART after controlling for age and sex. 
Research Question 3 (RQ3). Is viral suppression associated with the type of the home-
based caregiver (the person who supports the child or adolescent at home) among C&As 
on ART in Cameroon? 
Null Hypothesis (Ho3): Viral suppression is not significantly associated with the type of 
home-based caregiver (the person who supports the child or adolescent at home) among 
C&As on ART in Cameroon? 
Research Hypothesis (Ha3): Viral suppression is significantly associated with the type of 
home-based caregiver (the person who supports the child or adolescent at home) among 
C&As on ART in Cameroon? 
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Research Question 4 (RQ4. Is there a significant difference in the average proportions 
of the consistency in medication pickup for the different types of home-based caregivers 
(the person who supports the child or adolescent at home) among C&As on ART in 
Cameroon?  
Null Hypothesis (Ho4): There is no significant difference in the average proportions of 
the consistency in medication pickup for the different types of home-based caregivers 
among C&As on ART in Cameroon.  
Research Hypothesis (Ha4): There is no significant difference in the average proportions 
of the consistency in medication pickup for the different types of home-based caregivers 
among C&As on ART in Cameroon  
 In a quantitative study, it is appropriate to begin data analysis with a description of 
the various variables. I carried out that analysis and presented descriptive statistics for 
each of the variables included in the study. For continuous variables like age, consistency 
in medication pickup and viral load status, I presented results using descriptive statistics 
like mean, median, mode, standard deviations, maximum and minimum values, 
confidence intervals, and appropriate histograms and box plots to present findings for 
easy understanding. For the categorical variables, care model, type of home-based 
caregiver, sex, 12 months retention, I generated frequency distribution tables that 
displayed the results in graphical format for easy reading. Also, I used a bar chart and a 
pie chart to show the distribution of per region and zone. 
To respond to question one (RQ1), I ran a Chi-Square Test, binary, and multiple 
logistic regression models. I reported the Odds Ratio, the Chi-Square, which assesses the 
66 
 
Hosmer-Lemeshow Goodness of Fit Test of the model, and Wald test to assess individual 
variables. To respond to questions two and three, where the outcome variables were 
binary, I ran both binary and multiple logistic regression models using the sequential 
addition of variables into the model and interpreted their block statistics. I then reported 
the Odds Ratios, and my interpretation depended on the p-values, confidence intervals, 
the value of the Chi-Square test of its fitness, and tests of model coefficients. To respond 
to the fourth research question (RQ4), I used the one-way Analysis of Variance 
(ANOVA) test and used the F statistic and the Lavene’s statistics with their associated p-
values to interpret if there was a significant difference between the mean consistency of 
medication pickup for different types of home-based caregivers.  
Table 1  
The Dependent and Independent Variables Used in This Study 
 
Dependent variable Independent variables Covariates 
12-month retention rate  Care model Age 
Viral load status Home-based caregiver Sex 





Table 2  
Research Variables, Measures, and Coding 
 




Variable classification Variable coding 
1 12 months 
retention rate 
Categorical Nominal Two categories. 
Retained and not 
retained 
Retained = 0 
Note retained =1 
2 Viral load 
status 
Categorical Nominal Two categories. 
<1000 copies/ml = 
virally suppressed 
>1000 Copies/ml = 
virally not suppressed 
Virally suppressed = 
0 
Virally not 
suppressed = 1 
3 Age Categorical Nominal Two categories: <15-
year-old = children 
15- to 19-year-old = 
adolescents 
Children = 0 
Adolescents = 1 
4 Care model Categorical Nominal Three categories: 
support groups (SGs), 
standard clinic visit 




Support groups = 0 
Standard clinic 
Visits = 1 
Children and 
adolescent friendly 
clinics = 2 
5 Home-based 
caregiver 
Categorical Nominal Three categories: both 
biological parents, 
father alone or mother 
alone, other foster 
parents (aunt, uncle, 
sister, brother, others) 
Both biological 
parents = 0 
Father alone or 
mother alone = 1 
Foster parents = 2 
6 Sex Categorical Nominal Two categories: male 
& female 
Male = 1 









Threats to Validity 
 The representativeness of a study sample contributes to its external validity 
and generalizability of findings. This study included data from five of Cameroon's ten 
regions, which had a higher proportion of the total number of people living with HIV. It 
also included participants from rural, urban settings, public and faith-based institutions, 
French and English-speaking regions. It also had participants from Christian and Muslim 
communities, indicating a good mix of participants and cultures representing the 
Cameroonian population. The mixture in the sub-populations included as participants in 
the study, to a great extent, reflects the people in the SSA subregion. This mix increased 
the external validity of the study findings.   
 One of the assumptions critical for logistic regression is that the model must be 
correctly specified, including all the possible predictors, and should not include irrelevant 
predictors (Warner, 2013). This condition was not fully satisfied in this study because the 
predictor variables included were based on the research questions and data available and 
may not have been exhaustive, limiting the findings validity.  
Ethical Procedures 
 Before data collection, I obtained IRB approval to conduct the study from the 
National Ethics Committee, the Cameroon Baptist Convention Health Board IRB, and 
Walden University. The Walden University IRB gave me a temporal approval letter to 
enable me to obtain the national ethics approval. I was required to meet and share 
summary information about the study and request administrative letters of support before 
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the issuance of the national ethics approval. I met with key stakeholders and leaders of all 
the 27 facilities involved in the study to present the research and respond to any 
questions. This meeting gave them an understanding of the research and enabled them to 
provide administrative letters of approval for me to collect the data from their sites. One 
facility required additional approval from the National AIDS Control Committee, which 
was also obtained. The administrative approval letters were submitted to the National 
Ethics Committee before they issued the national ethical approval. Before final approval 
for me to collect data, the national Ethics approval letter was submitted to the Walden 
University in May 2020. In seeking the IRB approvals, I shared the data abstraction form 
to be used in data collection from the field and a confidentiality act with the various 
committees for review and approval. I also signed the confidentiality act before I started 
data collection. These approval letters were presented to the facilities' leaders and those 
of the ART clinics, who then gave me access to the registers and medical records. With 
all the approvals, I did not have any challenges in gaining access to data collection 
records. 
 During data collection, I reviewed the medical records and picked out the data 
required for the study as indicated on the approved data abstraction form, which did not 
include any identifiable client information but only use codes to identify individual 
patients. Data collection took place onsite without taking any of the medical records out 
of the clinic. After using the medical records, I returned them to their sources to be stored 
in the locked cupboards where they are usually kept while I went away with the data 
abstraction form. At the end of data collection in each facility, I had an out brief meeting 
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with the clinic leader to share with him/her what I did, and data collected. I then entered 
the data from the data abstraction forms into my computer and stored the hard copies in a 
locked cupboard in my study room. The computer's data was protected with a password 
and a copy backed-up in an external hard drive with password protection and was stored 
in my office. 
  After presenting the study findings and final approval of my dissertation, I will 
provide written feedback on the study findings to the various health facilities with 
suggestions for improving services for better outcomes. I will also share summary 
findings with the regional stakeholders with recommendations and suggestions for 
improvement based on existing evidence from other countries. At that point, I will 
destroy the hard copies of the data abstraction forms.   
 One other ethical issue that could come up in this study was the fact that I will used 
data from HIV programs while also working on HIV in the country. While this facilitated 
my access to data, I ensured that all ethical procedures were followed in every site. I 
explained my trip's purpose and introduced myself as a research student who came for 
research data collection. I presented the study approval letters, the purpose of the 
research, and encouraged the service providers to treat me during that visit as they will do 
for any other researcher.  
A summary of chapter three 
I described the research design, method of inquiry, study population, participant 
selection, study variables, data collection, cleaning, analysis plan, threats to the validity 
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of results, and ethical considerations. The results of the implementation of the study are 





Chapter 4: Results 
Introduction 
The purpose of the study was to investigate the association between 12 months 
retention on ART, the care models used to provide HIV care and related services, and the 
viral suppression status of C&As in Cameroon. I hoped to generate evidence on retention 
in care and viral suppression rates for the (C&As) on ART while identifying the care 
model with the best outcomes. I also sought to establish whether the type of home-based 
care provider is associated with viral suppression in C&As on ART. The study findings 
could contribute to the existing literature on the topic and inform program planning, 
funding prioritization, and national program scale-up strategies that promote specific 
high-impact interventions. 
Research Questions (RQ) and Hypotheses 
The study had four main research questions and null hypothesis as follows. 
  RQ1: Is there an association between the 12 months’ retention in HIV care and 
the HIV care model used for C&As while controlling for age and sex? The null 
hypothesis stated that “there is no significant association between the 12 months’ 
retention in HIV care and the HIV care model used for C&As on ART while controlling 
for age and sex.” 
  RQ2: Is there an association between viral suppression and the HIV Care model 
used for C&As while controlling for age and sex? The null hypothesis was that “there is 
no significant association between viral suppression and the HIV care model used for 
C&As while controlling for age and sex.”  
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  RQ3: Is viral suppression associated with the type of the home-based care 
provider (the person who supports the child or adolescent at home) among C&As on 
ART in Cameroon? The null hypothesis for this question was that “viral suppression is 
not significantly associated with the type of the home-based care provider (the person 
who supports the child or adolescent at home) among C&As on ART in Cameroon.” 
  RQ4: Is there a significant difference in the average proportions of the 
consistency in medication pickup for the different types of home-based care providers 
among C&As on ART in Cameroon? This question had the null hypothesis that “there is 
no significant difference in the average proportions of the consistency in medication 
pickup for the different types of home-based providers among C&As on ART in 
Cameroon.”  
  This chapter begins with a brief overview of the study purpose, statement of the 
research questions, and the null hypotheses. Next is a summary of the chapter’s content 
and a brief description of how the data were collected. The next section is the descriptive 
statistics for the various study variables where tables and charts are used to ease 
understanding. Next is the detailed results presented by the research question with tables, 
the exact statistics, confidence intervals, effect sizes, and other details for clarity. The 
chapter ends with a summary of the research findings and a transition into Chapter 5.  
Data Collection 
Data collection took place from June 2020 to August 2020, following receipt of 
all the IRB and administrative approvals from Walden University and the national ethics 
committee in Cameroon. The data collected were documented in the medical records for 
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participants from January 2019 to December 2019 from participant enrollment in the 
clinic and updated each clinic visit. As indicated in Chapter 3, there was a slight 
deviation from the study period (January 2018 to September 2019). This deviation was 
due to the long delay in obtaining IRB approval and because it was preferable to focus on 
more recent results for the participants. However, for participants in care for more than 2 
years who did not have any documented viral load result in 2019 but had one in 2018, the 
result of 2018 was collected. Not all clients had data for retention in care and consistency 
in medication pickup. This missing data was found in the ART registers, which were not 
available in some sites during data collection because they were being used at the region 
office for data validation. 
The calculated minimum sample size for the study was 1,188, and the total sample 
collected was 2,503. This difference is because more data was available for eligible 
participants in the selected study sites than anticipated. The study participants included 
were C&As aged 0 to 19 years enrolled on ART in study sites for at least 1 year and had 
at least one viral load test result documented against their name in the ART register or 
their medical file. The study involved 27 health facilities in five of the 10 regions of 
Cameroon, which are the Center, Littoral, West, Southwest, and Northwest regions. 
These regions have used innovative models of care in the past 5 years to manage C&As 
on ART. The study sites included facilities in the urban and rural areas of the regions. 
Therefore, the participants drawn from five regions were a good representative sample of 
C&As on ART in Cameroon, which increased the findings' generalizability. 
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The data were collected using a data abstraction form and entered an Excel 
database designed for the study. Only participants with a documented viral load result 
during the study period were included in the analysis. The data were verified for 
completeness and consistency, and a codebook generated for the categorical variables 
before exporting the data into SPSS Version 25 for analysis. In SPSS, the data were again 
reviewed to ensure that it did not have string variables, had the right labels and values 
before the analysis. 
Descriptive Statistics for the Study Sample 
The study had 2,503 participants, and the analysis involved seven key variables, 
including care model, sex, age, viral load results, consistency of medication pickup, 
retention in care, and type of home-based caregiver (provider).  
Descriptive Statistics for Categorical Variables 
There were six categorical variables in the study. Each of the 2,503 study 
participants belonged to the model of care used in the site. The support group model had 
the least number of participants (n = 396), representing 15.8% of the entire study 
population. The Standard clinic model had more participants than the support groups (n = 
612, 24.5%), whereas the child & adolescent friendly clinic model had more than half of 







Table 3  
Descriptive Statistics for the Care Model 
                                                    Frequency  Percentage 
Support group         396    15.8   
Standard clinic visit         612    24.5  
Child & adolescent friendly clinic      1,495   59.7  
Total          2,503   100.0   
 
Information on participants’ sex was available for 2,489, and 14 (0.6%) 
participants had missing data. There were fewer males than females in the study. There 
were 1,176 males (47%) compared with 1,313 females (52.5%). 
Table 4  
Descriptive Statistics for Sex      
          Frequency       Percentage   
Male     1,176   47.0   
Female    1,313   52.5   
Missing system   14   .6   
Total     2,503   100.0   
 
Of the 2,503 study participants, a total of 2,180 had data on the retention status, 
whereas 323 had missing values (12.9%) due to the unavailability of registers during data 
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collection. Among the 2,180 participants, 249 were not retained in care, representing 
11.4%, whereas 1,931 (88.6%) were retained. 
Table 5  
Descriptive Statistics for Retention Status    
          Frequency       Percentage   
Retained     1931   77.1   
Not retained     249   9.9   
Missing system    323   12.9   
Total      2503   100.0   
 
For the type of home-based caregiver, a total of 2,032 (81.2%) participants had 
valid data, whereas 471 (18.8%) had missing values due to insufficient documentation in 
the medical files. The “one parent” category had most of the study participants (n = 851, 
41.9%) and included C&As taken care of by a single mother or single father. This was 
followed by the “Others” category (n = 634, 31.2%), which included all children taken 
care of by aunts, uncles, grandparents, sisters, brothers, and others. The category of both 








Table 6  
Descriptive Statistics for Type of Caregiver     
     Frequency  Percentage   
Both parents    547   21.9   
One parent    851   34.0   
Others     634   25.3   
Missing system   471   18.8   
Total     2503   100.0   
  
For viral load results, the total number of participants analyzed for this variable 
was N= 2,503, and there was no missing data since it was one of the inclusion criteria for 
the study. The most recent viral load result for each participant was documented as a 
continuous variable with values ranging from 0 copies/ml representing an undetectable 
viral load, while the highest value was 37,800,000 copies/ml. Since one of the dependent 
variables was viral suppression, the viral load values were recoded into "virally 
suppressed" with values from 0 to <1000 copies/ml and "virally unsuppressed" with 
values >1000 copies/ml. A total of n=1,578 participants had viral suppression 







Table 7  
Descriptive Statistics for Viral Load    
      Frequency  Percentage  
Suppressed     1578   63.0   
Not suppressed    925   37.0   
Total      2503   100.0   
  
Age was measured in years with 2,494 participants who had valid data and nine 
missing values. The youngest of the participants was a year old (Minimum value) while 
the oldest was 19 years old (Maximum value). The mean age was 11.9 years, the median 
was 12 years, and the mode was 15 years. The standard deviation was 4.549, the range was 
18, and the variance was 20.697. Both Kurtosis and skewness were negative at -0.891 and 
-0.223, respectively. The age variable was recoded into two categories: 0 – 14 years for 
children and 15 – 19 years for adolescents. Descriptive statistics showed that 66.5% of the 
2,494 participants were children, while 33.5% were adolescents. 
Table 8  
Descriptive Statistics for Age   
      Frequency  Percentage  
Children     1,658   66.2   
Adolescents      836   33.4  
Missing      9   0.4  




In addition to describing the data by the study variables, data was also 
disaggregated by region and by zone. Looking at data by region, the Northwest region 
had the highest number of participants (n=620, 24.8%) followed by the West region 
(n=593, 23.7%) while the Center region had the least (n=323, 12.9%). The study sites 
included those from both rural and urban areas referred to as zones. The participants' 
distribution by zone revealed that the urban areas had more participants than rural areas 
(55% compared to 45%). This reflects the availability of pediatric ART services, which 
were mostly limited to big hospitals in the cities until five years ago. I had to include 
several sites in rural areas to have 45% of participants from there. 
Descriptive Statistics for Continuous Variables 
The description of continuous variable focused on the valid values, minimum and 
maximum values, measures of central tendency and measures of variance (Frankfort-
Nachmias, & Leon-Guerrero, 2018).Consistency in medication pickup had valid data for 
2,198 participants and 305 missing values due to registers' unavailability or incomplete 
documentation. The minimum value was 8.3%, while the maximum was 100% 
representing those who picked medication for all the 12 months. The mean was 86.94%, 
the mode was 100%, and the median was 100%. The standard deviation was 20.488, the 
variance was 419.76, while the range was 91.7. The skewness was negative at -1.987, while 




Table 9  
Descriptive Statistics for the continuous variable -consistency in medication pickup  
        Consistency in med pickup 
N Valid        2198 
 Missing       305 
Mean         86.943 
Median        100.000 
Mode         100.0 
Std. Deviation        20.4881 
Variance        419.764 
Skewness        -1.987 
Std. Error of Skewness      .052 
Kurtosis        3.441 
Std. Error of Kurtosis       .104 
Range         91.7 
Minimum        8.3 
Maximum        100.0 
 
The distribution of the continuous variables was examined using a boxplot and a histogram, 





Figure 3  
A box plot for consistency in medication pickup 
 
Figure 4  





Figure 3 shows a boxplot that had most values in the upper quartile, several 
outliers in the lower quartile, and the curve highly skewed to the right (negatively 
skewed), as seen in Figure 4. 
Study Results by the Research Questions 
The first research question sought to know if there is an association between the 
12 months’ retention in HIV care and the model of care used for C&As after controlling 
for age and sex. During data collection, retention in care was recorded as a dichotomous 
variable with “retained” and “not retained” as the outcomes. For this reason, the Chi-
square test and multiple logistic regression were used for analysis to investigate the 
association between retention and the care model instead of the multinomial regression 
model proposed in chapter 3. The analysis changed because the 12 months retention in 
care variable which was previewed to have three categories ended up as dichotomous 
variable. The Chi-Square test is non-parametric, can determine if there is an association 
between two categorical variables (retention and care models in this case) and does not 
require that the data have a normal distribution (Frankfort Nachmias & Leon-Guerrero, 
2015). The Chi-Square also provides reliable information on associations if there is the 
independence of observations and the expected cell frequencies are greater than five 
(Frankfort Nachmias & Leon-Guerrero, 2015). The data for this study met these 
assumptions.  
While the 12 months retention rate for the study sample was 77.1%, including the 
missing values, Retention in Care for the SCVs was 87%, followed by that for the SGs 
(78%) and that for the CAFCs was the least (77%). The chi-square test result revealed no 
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significant association between the retention at 12 months, and the model of care used for 
the C&As on ART [X2(1, N=2180) =0.681, p = .711].  
To predict if there was an association between the 12 months' retention in HIV 
care and the HIV care model used for C&As while controlling for age and sex, a stepwise 
multiple logistic regression model was conducted. Overall, 88.6% of the study 
participants were retained in HIV Care, excluding the 323 missing values that constituted 
12.9% of the study sample. The baseline binary logistic regression model (Block 0) 
showed a significant prediction of retention without any exposure variable (Wald statistic 
of 63.862 and OR= 0.129, p< .0001). The Omnibus Tests of Model Coefficients, which 
compares the model to the baseline (block 0), revealed that the block 1 model was not a 
significantly better predictor of the relationship between the two variables than the block 
0 model (X2 = .0001, p = .986). The block 1 model's output showed no association 
between the model of care and retention status (OR = 0.998, p = .986), confirming what 
was observed in the Chi-Square test. The OR's confidence interval was from 0.837 to 










Table 10  
The Output of Binary Logistic Regression for an association between 12 months retention 
in care and model of care          
  B S.E. Wald  df Sig. Exp(B)  95% C.I. for EXP(B) 
            Lower Upper 
Step 1a 
Care Model -.002 .090 .000  1 .986 .998    .837  1.190 
Constant -2.046 .146 197.688 1 .000 .129  
       
The addition of sex separately to the model showed no significant difference in 
the output. Age as a categorical variable added independently showed no significant 
association with retention at 12 months (OR=0.795, p = .122) with a confidence interval 
from 0.595 – 1.063, which includes 1. Age did not also have any significant influence on 
the association between the model of care and retention at 12 months. Putting the 
predictor variable plus sex and age into the model at the same time still did not show any 
significant relationship between retention at 12 months and model of care. So, while 
controlling for age and sex, there was no statistically significant association between 
retention in care at 12 months and the care model used for C&As in HIV care [OR=1.014 
(0.948 – 1.211) p = .876]. Therefore, we failed to reject the null hypothesis and did not 





Table 11  
The Output of Multiple Logistic Regression for an association between 12 months 
retention in care and model of care while controlling for Age and Sex    
   B S.E. Wald df Sig. Exp(B)   95% C.I.for EXP(B) 
         Lower  Upper 
Step 1a 
Care Model  .014 .091 .025 1 .876 1.014 849  1.211 
 Sex (1) .151 .135 1.245 1 .265 1.163 892  1.515 
 Agecoded (1) .225 .148 2.305 1 .129 1.252 937  1.675 
 Constant -2.298 .198 135.053 1 .000 100   
a Variable(s) entered on step 1: Care Model, Sex, Agecoded.    
  
The second research question focused on the association between viral 
suppression and the HIV Care model used for C&As after controlling for age and sex. 
The research hypothesis was that there is an association between viral suppression and 
the HIV Care model used for C&As after controlling for age and sex. The study sample's 
overall viral suppression rate was 63.6%, and the best suppression rate came from the SG 
model (68.3%). The CAFCs had a 64.4% suppression rate, while the SCV had a 
suppression rate of 58.4%. The Chi-Square test for an association between the care model 
and viral suppression showed a significant association between the two variables, as seen 
in the data [X2(1, N=2503) =9.949, p = .007]. This suggested that there was a statistically 
significant association between viral suppression and the models of care. The Cramer's V 
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test for the strength of the association was 0.63 (p = .007). Cramer's V statistic suggested 
that the model was 63% effective in predicting the relationship between the two variables 
(Frankfort Nachmias & Leon-Guerrero, 2015).  
The output of a binary logistic regression model for the viral suppression and care 
model showed an overall significant association (OR=0.783, CI: 0.665 – 0.922, p = .003). 
indicating that the logistic regression model predicting the Odds of viral suppression was 
significant. The output of a binary logistic regression model for viral suppression and sex 
showed a significant association (OR=0.783, CI: 0.665 – 0.922, p = .003) while the 
association between age and viral suppression was not significant (OR=1.044, CI:0.879 – 
1.240, p = .622). 
A stepwise multiple logistic regression model was again used to determine if the 
observed association in the binary logistic regression model will change while controlling 
for age and sex. This was used because the dependent variable, though collected as a 
continuous variable, was recoded into a dichotomous variable (Dionne-odom et al., 
2016), with viral suppression being the outcome of interest. The binary logistic regression 
model output on the baseline (Block 0) showed that 63% of the study participants were 
virally suppressed. The baseline model was statistically significant with a Wald statistic 
of 166.366, and an OR = 0.586 (p< .000). The Omnibus Test of Model Coefficients for 
the model was statistically significant (X2 = 9.915, p = .007), confirming that the model 





Table 12  
Binary logistic regression output for viral suppression and Model of care  
   B S.E. Wald  df Sig. Exp(B)  95% C.I. for EXP(B) 
         Lower  Upper   
Step 1a 
Care Model    9.915  2 .007    
 Care Model (1) -.157 .120 1.719  1 .190  .854    .675  1.081 
 Care Model (2) .240 .098 6.011  1 .014  1.272    1.049 1.541 
 Constant  -.570 .054 112.1 1 .000  .565   




Table 13  
Categorical Variables Coding     
       Frequency Parameter coding  
(1)                 (2) 
Care Model Support Group   396  .000  .000 
 Standard Clinic Visit    610  1.000  .000 
 Child & Adolescent Friendly Clinic  1483  .000  1.000 
Agecoded Children    1653  .000  
  adolescents    836  1.000  
Sex  Male     1176  .000  
  Female    1313  1.000 
Viral Sup coded 
  Suppressed    1578  .000 
  Unsuppressed     925  1.000 
Age  Children    1658  .000  
  Adolescents     836  1.000 
 
Overall, the care model in which the C&As were enrolled had a significant 
association with the viral suppression status (p = .007). Compared to the Support Group 
model (reference group), the Children & Adolescent Friendly clinics model had a 
statistically significant association with viral suppression (OR=1.272, CI: 1.049 – 1.541, 
p = .014). After adding the covariate “sex” to the model, it still showed a significant 
90 
 
association between the variables (viral suppression and model of care) with similar Odds 
Ratios and the confidence interval plus a slight increase in alpha (p = .024). The variable 
sex in the model was also significantly associated with viral suppression (OR= 0.788, 
CI:0.669 – 0.928, p = .004). Upon adding the variable "age" into the model, both the 
association between the Child & Adolescent Friendly corners and sex remained 
significant. In contrast, age did not show any significant association with viral 
suppression both in the binary and multiple logistic regression models (OR=1.078, CI: 
0.905 – 1.283, p = .399).  
Table 14  
Multiple logistic regression output for viral suppression and Model of care while 
controlling for age and sex        
  B S.E. Wald df Sig. Exp(B)   95% C.I.for EXP(B) 
           Lower        Upper 
Step 1a          
Care Model    9.666 2 .008    
Care Model (1) -.165 .120 1.878 1 .171  .848    .670  1.073 
Care Model (2)  .235 .100 5.581 1 .018  1.265   1.041  1.538 
Sex   -.239 .083 8.180 1 .004    .788    .669  .928 
Agecoded  .075 .089 .710 1 .399    1.078   .905  1.283 
Constant  -.465 .078 35.981 1 .000    .628   
a Variable(s) entered on step 1: Care Model, Sex, Agecoded.    
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From the statistics, sex had an independent association with viral suppression both 
as a standalone variable and when combined with the model of care, while age had no 
statistically significant association in both scenarios. Sex modified the association 
between viral suppression and the care model only slightly by reducing the Odds Ratio 
from 1.272 (1.049 – 1.541) to 1.250 (1.030 – 1.516). The final output for the multiple 
logistic regression model showed that C&As enrolled in the Child and Adolescent 
Friendly clinics had an odds of being virally suppressed, which was 1.265 times higher 
than that for children in the support group model was statistically significant at p = .018. 
Also, sex was significantly associated with viral suppression, and females were 0.788 
times more likely to be virally suppressed than males.  
Summarily, there was a significant association between viral suppression and 
model of care for C&As in HIV care while controlling for age and sex. Sex had an 
independent statistically significant association with viral suppression, whereas age did 
not. The odds of achieving viral suppression were 1.265 times higher in C&As enrolled 
in the CAFC model than those enrolled in the SG model. With these findings, the 
research hypothesis of an association between viral suppression and care models was 
accepted and the null hypothesis of no association between the two variables was 
rejected. 
 In the third research question, the focus was on the association between viral 
suppression and the type of home-based caregiver (the person who supports the child or 
adolescent at home). The Null hypothesis was that there is no association between viral 
suppression and the type of home-based care provider for the C&As in care. The outcome 
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variable was viral load status recoded into "virally suppressed" and "virally 
unsuppressed" with viral suppression as the outcome of interest. The type of home-based 
care provider had three options, including "both parents", "single parent," who was 
mother alone or father alone, and "Others" (foster parents), including grandmother, sister, 
uncle, aunt, and other categories as found in the field. 
The viral suppression rate for all the study sample (N=2,038) was 66.1%, with the 
highest seen in children who had both parents as the caregiver (67.0%), followed by the 
single parent category (66.9%) and then others with 64.4%. From observation, the viral 
suppression rates were similar across the three types of care providers, with a difference 
of less than 3%. A binary logistics regression model revealed no statistically significant 
association between viral suppression and the type of home-based care provider (Wald 
statistics of 1.123 and p = .570). This model was well fitted, as seen in the statistically 
significant baseline Wald statistics of 196.928 (p < .0001) and the statistically 
insignificant Chi-square for the Omnibus Test of Model Coefficients (X2=1.119, p = 
.571). Though not initially included in the hypothesis, sex and age were added to the 
model to see if they may mediate the relation between viral suppression and type of 
caregiver at home, but there was still no significant association. Therefore, the alternative 
hypothesis of an associated between viral suppression and type of home-based caregiver 
was rejected. The null hypothesis of no association was accepted because I did not find 
enough statistical evidence to conclude that there is a significant association between the 




Table 15  
The Output of Binary Logistic Regression for an association between viral suppression 
and the type of home-based care provider         
        B    S.E.      Wald     df  Sig.  Exp(B)  95% C.I.for EXP(B) 
          Lower   Upper 
Step 1a 
Type of Caregiver   1.123    2       .570    
Type of Caregiver (1)     .010  .116    .007     1        .933  1.010        .804    1.268 
Type of Caregiver (2)     .112  .123    .831     1        .362  1.119        .879 1.423 
Constant      -.696 .091    58.81    1        .000  .499   
a Variable(s) entered on step 1: Type of Caregiver.      
 The fourth research question was on the association between proportions of the 
consistency in medication pickup and the home-based care provider type. The alternative 
hypothesis stated that "there is a significant association between the proportions of 
medication pickup and type of home-based care provider for C&As in Cameroon." 
Consistency in medication pickup was measured as a continuous variable, and 
proportions calculated from the number of months out of the 12 months of the year that 
the C&As picked medications. The average proportion of consistency in medication 
pickup was 85% for all the three types of home-based care providers, unlike what was 
expected. I planned to use the One-Way ANOVA statistical test to compare the means 
proportions of the consistency in medication pickup by type of home-based caregiver. 
However, upon examining the data, the distribution was not normal and was negatively 
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skewed (skewness = -1.987). The test for normality showed significant p-values for the 
Shapiro-Wilk statistic for all three groups indicating the inappropriateness of the One-
Way ANOVA test. I transformed the values into logarithm values, but the distribution 
was still not normal. I therefore decided to use the Kruskal – Wallis statistical test, which 
is non-parametric, to compare the means in the three groups and see if they are the same. 
The Kruskal – Wallis Statistics was 1.243, p = .537. I did not carry out multiple 
comparisons because of the non-statistically significant result indicating that there is no 
significant difference across the groups. Therefore, I failed to reject the null hypothesis 
and did not have enough evidence to conclude that the distribution of the consistency in 
medication pickup is significantly different across the categories of type of home-based 
caregiver.  
Table 16  
The Output of a Kruskal – Wallis test for a significant difference in the proportion of 
consistency in medication pickup across the types of home-based care provider 
     Consistency in Medication pickup 
Kruskal-Wallis H Statistic   1.243 
Df         2 
Asymp. Sig.     .537   
In addition to responding to the research questions, I also looked at the data by 
site, zone, and region. There were statistically significant differences by the site (F = 
4.029, p < .0001), by zone (F=5.691, p = .017) and by region (F = 6.617, p < .0001). 
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These results will be exploited further subsequently as they may reveal additional 
information that may strengthen program implementation.  
Summary of study findings 
The study data analysis generated evidence to reject the null hypothesis for one 
research question and failed to reject it for some. I failed to reject the null hypothesis in 
the first research question because there was no statistically significant evidence of an 
association between retention in HIV care at 12 months and the model of care while 
controlling for age and sex. Age had an independently significant association with 
retention in care but did not have a statistically significant influence on the association 
between retention and the care model. Sex had no significant influence in the model and 
failed to have an independent statistically significant association with retention. For the 
second RQ, I found a statistically significant association between viral suppression and 
care model while controlling for age and sex. The odds of viral suppression were 1.265 
times higher in C&As enrolled in the Child and Adolescent Friendly clinic model than 
those enrolled in the support groups model while controlling for age and sex. I, therefore, 
rejected the null hypothesis of no association between viral suppression and care models 
while controlling for age and sex. 
The analysis in response to RQ3 found no statistically significant evidence to 
reject the null hypothesis of no association between viral suppression and the type of 
home-based care provider (Chi-square for the Omnibus Test of Model Coefficients 
(X2=1.119, p = .571). In the same light, the Kruskal – Wallis test conducted to answer 
RQ4 generated an Kruskal - Wallis-statistics of 1.243 (p = .537). There was therefore no 
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significant association between viral suppression and the type of home-based caregiver. 
The alternative hypothesis of an association between the proportion of consistency in 
medication pickup, and the type of home-based caregiver rejected and the null hypothesis 
of no association between the two variables was accepted. Therefore, the null hypothesis 
for the four research questions was rejected only for RQ2, and there was no evidence to 
reject the null hypothesis for RQ1, RQ3, and RQ4. 
The next chapter (chapter 5) will discuss these findings, conclusions based on the 
results, limitations of the study, recommendations for further research, implications for 







Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this quantitative retrospective cohort study was to explore whether 
retention in HIV care and viral suppression are associated with the model of care used in 
the clinics and the type of home-based care provider who supports the C&As in 
Cameroon. The objective was to compare the two outcomes (retention in care at 12 
months and viral suppression) for the three models of care used in pediatric and 
adolescent clinics with the hope of identifying the model and type of care provider with 
the best retention in care and viral suppression rates. The three models of care were SGs, 
SCVs, and the CAFCs. The second research objective was to explore if the type of care 
provider at home (both parents, single parent, and foster parents) is associated with viral 
suppression in C&As on ART in Cameroon. The study had just two covariates, age and 
sex, because these had documented data in the data sources used. The initial hypotheses 
were that C&As enrolled in the CAFCs where there has been much investment in recent 
years, and those taken care of at home by their biological parents will have better 
outcomes than others. 
This study was a quantitative study in which a retrospective cohort review 
approach was used to abstract and analyze data from existing secondary data sources in 
the clinics for C&As (0-19 years old) who were current on ART in Cameroon from 
January 2019 to December 2019. I selected this study design due to the convenience of 
using existing data, saving time, and cost. The retrospective design was also preferred 
because the objective was to work with data collected from routine care settings, 
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representing the real situation. There were three dependent variables (12 months retention 
in care, viral suppression, and consistency in medication pickup), two independent 
variables (model of care and type of home-based care provider), and two covariates (age 
and sex) involved in the study. The data for each of these variables was available either in 
the ART registers or the individual medical records existing onsite.  
I used a data abstraction form to collect data from the study sites for participants 
who were C&As (0-19 years old) enrolled on ART and who were eligible for inclusion in 
the study. One key inclusion criterion was the presence of a documented viral load result 
within the study period. The most recent viral load result was considered for participants 
who had more than one. The collected data were entered into an Excel database and 
exported to SPSS Version 25 for analysis. The statistical tests used depended on the 
research question and included the chi-square test, binary and multiple logistics 
regression, and the one-way ANOVA test. Some of the study findings were not as 
hypothesized, as seen in Chapter 4. 
The need to prioritize and target appropriate health interventions that significantly 
impact the population necessitated this study. This prioritization is more critical in 
settings with competing health priorities such as Cameroon and other countries in SSA, 
which are the hardest hit by HIV but have limited resources to fight the pandemic 
(Zakumumpa et al., 2017). Findings from this study will hopefully contribute in filling 
the gap in the literature in the understanding of which model of care yields the best 
outcomes in a routine care setting and will equally open up other areas for research given 
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the limited existing literature on some aspects of this study such as the role of the home-
based care provider.  
The study data analysis generated evidence to reject the null hypothesis for the 
second research question only. The results for Research Questions 1, 2, 3, and 4 instead 
showed evidence to accept the null hypothesis. Therefore, based on the study data, there 
was no statistically significant evidence of an association between retention in HIV care 
at 12 months and the care model while controlling for age and sex [OR=1.014(0.948 – 
1.211), p = .876]. There was a significant association between viral suppression and care 
model while controlling for age and sex [X2(1, N = 2503) = 9.949, p = .007]. More 
specifically, the analysis showed that the odds of achieving viral suppression was 1.265 
times higher in C&As enrolled in the CAFC model compared with those enrolled in the 
SG model. There was no statistically significant evidence for an association between viral 
suppression and home-based care provider (X2  =1.119, p = .571). Last, I also did not find 
any evidence of an association between the proportion of consistency in medication 
pickup and type of home-based care provider (F = 1.576, p = 1.93).  
Interpretation of the Findings 
 This study’s findings confirm and diverge from what was hypothesized and what 
exists in the literature on retention in HIV care and viral suppression. This section 
contains a review of the findings and their interpretation compared to previous studies by 
the research question. 
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The 12-Month Retention in Care and Models of Care 
Retention in care is a critical step in the HIV care cascade since people need to 
stay in care and adhere to treatment to achieve viral suppression and live healthy lives. A 
successful HIV program is one with good retention in care, and the services offered in the 
clinic could be a good attraction for C&As to stay in care. While controlling for age and 
sex, retention in care at 12 months showed no statistically significant association with the 
three care models (OR = 0.998, 95% CI: 0.837 to 1.190, p = .986). Therefore, none of the 
care models had a significantly higher retention rate compared to others. 
In the CAFCs model, participants received monthly age-adapted education. They 
had much interacting among themselves, similar to the adherence clubs, family clinic 
days, and decentralized care services, which showed better outcomes in Uganda and 
South Africa (Fox et al., 2019; Graves et al., 2018; Tsondai et al., 2017). These authors 
found a statistically significant association between care models introduced as quality 
improvement interventions and improved retention in care. Still, they only compared 
their intervention to the standard clinic visit. This study compared three models of care 
and used secondary data from a routine care setting. It was not possible to control for the 
several other factors which are associated with retention in care for C&As such as the 
availability of the medications, compassionate service providers (Cluver et al., 2018), 
long distances, cost of transportation and insurance (Yehia et al., 2015). A prospective 
study in routine care settings that controls for all these possible associated factors may 
yield more reliable results when the models of care are compared. 
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A previous study conducted in the ten regions of Cameroon in 2014 found a 12-
month retention rate of 60.4% with no difference between adults and children (Billong et 
al., 2016). Another study found low viral suppression in big hospitals than small clinics 
(Tchouwa et al., 2018). This research, which focused only on C&As and covered five of 
the 10 regions, recorded a retention rate of 77.1%, including the care model’s missing 
values and retention rates by model of 77%, 87%, and 78% for CAFCs, SCV, and SGs, 
respectively. Though there was no statistically significant difference in the retention rates 
by model, the least retention rate was in the CAFCs, which were mostly in the large 
hospitals with more prominent pediatric HIV clinics and much investment. This CAFC 
was also the model with the highest number of participants. Because pediatric care 
services were mostly centralized in these large hospitals until a few years ago, outlying 
health facilities in the remote areas had to refer C&As in need of ART to the big hospitals 
for care. Possible predictors of these results, which were not included in this study and 
might have contributed to the low retention rates for C&As in CAFC than expected, are 
challenges of long distances, bad roads and high cost of transportation, need to visit 
clinics monthly, and the need to be accompanied by care providers. It is worth conducting 
further studies, including qualitative studies, to understand the role of some of these 
factors in retention in general and in these big pediatric ART clinics specifically. In this 
study, age had a significant independent association with 12 months of retention in care 
(OR = 0.969, p = .034). Still, it did not significantly influence the association between 
retention and the model of care. Investigating the associations in children compared with 
adolescents may yield different results and constitute a topic for further research. 
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Viral Suppression and Models of Care 
I found a statistically significant association between viral suppression and the 
models of care (OR = 0.783, CI: 0.665 to 0.922, p = .003), which enabled me to reject the 
null hypothesis of no association as anticipated. Routine clinic visits had the lowest viral 
suppression rate, pointing to more psychosocial support and clinical monitoring of the 
C&As in care. The psychosocial and peer support found in the SGs and CAFCs is absent 
in the SCVs. A randomized control trial conducted in Uganda and Kenya by Dalsone 
Kwarissima et al. (2017) found improved retention rates and viral suppression in 
comparing a streamlined care model to standard care. This study was not an RCT and did 
not see a significant difference in the model’s retention rates, which does not align with 
Uganda and Kenya’s study. The general belief is that if there were no significant 
differences in retention by the model of care, there should not also be a difference in viral 
suppression by the model of care using the same data within the same period. Patients 
who are retained in care are likely those who have been consistent on treatment and 
should have higher probabilities of achieving viral suppression. Interestingly, this study 
does not support the thinking and points out that being retained in care is not synonymous 
with taking medications as prescribed or taking the right medications. The patients need 
to be on the right medications, right doses, and take them as prescribed to achieve and 
sustain viral suppression.  
Many efforts were made to improve viral suppression rates and viral load 
coverage in the last two years in Cameroon. The government’s decision from January 
2020 to offer free viral load testing to all in need is an excellent opportunity to increase 
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coverage. Viral load coverage has been notably lower for C&As compared with adults 
(Arpadi et al., 2017; Ferrand et al., 2017). It is rampant in Cameroon to have health 
facilities managing C&As go out of stock of medications for some months. Children 
often change the regimen to what is available, some have repeated high viral load results, 
and there is the possibility of viral rebound (Teasdale et al., 2018). Several C&As in care 
have not done a viral load test, and some not yet on ART. Strengthening HIV case 
finding in children, enrolling those HIV positive on ART, and scaling up viral load 
testing for those eligible is important. There is also a significant need to improve the use 
of results to better manage the C&As in care for improved viral suppression rates if there 
is hope for an HIV free generation in the future.  
The overall viral suppression rate for the study was 63.6%. A previous study 
carried out in Cameroon found 72% for a cohort of patients who had been on ART for 12 
– 24 months (Tchouwa et al., 2018). Another study conducted in one hospital in Yaounde 
involving 71 children aged 2-18 years on protease inhibitor-based ART recorded a 74.7% 
viral suppression rate (Nlend et al., 2019). The viral suppression rate from CAMPHIA 
was 70% (CAMPHIA, 2018). While the CAMPHIA and the study by Tchouwa and his 
team covered both adults and children in the whole country, the study from the hospital in 
Yaounde focused on children but had a small sample, focused only on a specific regimen, 
and was not representative of the population of C&As on ART. To a great extent, these 
findings represent the country's actual situation, as seen in the sample size, geographic 
coverage, and the participants were from a routine care setting, including those from big 
and small hospitals from both rural and urban areas.  
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Previous literature documents lower viral suppression rates for children than 
adults attributed to various factors, including their dependence on care providers for their 
care (Closson et al., 2019; Enane et al., 2018). Their dependency nature increased their 
risk of defaulting or getting lost-to-follow-up. One Cameroonian study attributed the low 
rates of viral suppression in children to limited knowledge of health care workers in 
managing the C&As on ART (Penda et al., 2019). The service providers in the clinics 
with CAFCs received more training and technical support in the management of the 
C&As compared to smaller centers with fewer C&As. Most often, the C&As also receive 
a closer individual follow-up, transport subsidies for group meetings, and sometimes their 
care providers were invited for educative meetings to improve their management of the 
C&As at home. The study findings suggest that it may be essential to consider investing 
in some of these strategies in pediatric clinics for improved outcomes in C&As. 
Notwithstanding, the viral suppression rate even in the C&As benefiting from these 
interventions was still less than 70% (far less than the desired 90%) which casts doubts 
on their effectiveness. It may be essential to review the care package's content in the SGs 
and CAFCs to identify why the viral suppression rate in these models is still suboptimal 
though better than that of the SCVs. 
Viral suppression and type of home-based care provider 
In this study, there was no statistically significant association between viral 
suppression and the type of home-based care provider. Therefore, the viral suppression 
rates for the C&As did not differ much by the kind of home-based care provider (67.0% 
for both parents, 66.9% for single parents, and 64.4% for foster parents). A study 
105 
 
conducted in Asia found out that C&As were more likely to default from care if they 
were living with other care providers who were not their biologic parents (Huy et al., 
2016), which is what several stakeholders and service providers in Cameroon think is 
responsible for high viral load in children. The study conducted in the hospital in 
Yaounde found out that 22 of the 71 C&As were orphans, and being an orphan was not 
associated with viral suppression (Nlend et al., 2019). The findings from the Asian study 
and the Yaounde hospital study are contradictory but not comparable, given the sample 
sizes and representativeness of the Yaounde study sample. These findings confirm the 
Yaounde study's finding and are likely to be challenged by many stakeholders who 
believe that orphanhood is a risk factor for high viral load. These findings should 
stimulate further research, including qualitative studies on the topic, which may uncover 
other underlying factors that contribute to the high viral load even in C&As living with 
their biological parents, some of whom are also on ART.  
Medication pickup and type of home-based care provider. 
For the consistency in medication pickup, the hypothesis was there is a significant 
difference in the average proportions of the consistency in medication pickup for the 
different types of home-based providers among C&As on ART in Cameroon. Feedback 
from interactions with pediatric service providers suggests that parents taking care of 
their children on ART are more likely to follow-up, keep to the appointment dates, avoid 
missed opportunities compared to foster parents who have other responsibilities. These 
findings showed no statistically significant difference in the proportions of medication 
pickup in the three groups, and single parents constituted 42% of their home-based care 
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providers. Some studies in the literature have documented family stability associated with 
adherence to ART (Shabalala et al., 2016; Sherr et al., 2016). Another study highlighted 
the burden of home-based care for children living with HIV (Osafo et al., 2017), which 
may be more bearable to biological parents than other care providers or single parents. In 
some sites, most of the care providers were grandmothers, uncles, and aunts. 
Interestingly, they were able to remember to go to the clinic for medications, remind the 
C&As to take the medicines, like what happened in the “both parents” category. The lack 
of an association between viral suppression and type of home-based caregiver was 
identical to results of a study conducted in India, which compared the quality of life in 
children living in foster homes to those living with their parents and found no significant 
difference (Kamalakshi et al., 2018). The contradiction in the evidence suggests that there 
may be other associated factors that further research needs to uncover concerning care 
providers of C&As on ART.  
Study Findings in the Context of the SCT  
The theory that guided this study was the SCT, which was first articulated by Albert 
Bandura (Bandura, 1986). It highlights the importance of critical concepts such as personal 
standards, self-reflection, self-regulation, environmental circumstances, and influence on 
behavior, suggesting that external and internal factors cause people to regulate their 
behavior following cognitive processes and environmental manipulations (Mulhollem, 
2017). The care model in which the C&As were enrolled and the environmental 
manipulations and the care psychosocial support received could influence their behavior 
and eventual viral suppression status.  
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The study found an association between viral suppression and care models, which 
aligns with the theory, pointing to the need for more friendly environments in the ART 
clinics for C&As. The therapeutic education in the CAFCs and SGs seems to have played 
a key role in improving treatment literacy and regulating behavior towards taking the ARVs 
leading to higher viral suppression rates. Evidence from existing literature showed an 
increase in understanding why quality care for C&As improves outcomes and self-efficacy 
(Bröder et al., 2017). These are attributes of the SCT and core aspects of the care package 
in CAFCs. The findings did not show that the type of home-based care provider matters in 
viral suppression. The single and other foster parents managing the children likely did their 
best to provide a supportive environment at home, favoring taking medications and 
medication pickup, like what the children with both parents also received. 
Limitations of the Study 
 The study used existing data, which saved time and cost. However, it was 
prone to several limitations common in longitudinal studies. For instance, all participants 
receiving care from a clinic that uses a particular care model were attributed to that model 
of care even if they did not consistently receive all the model's services, which could 
introduce bias. The study variables were limited to data routinely collected and 
documented in the sites' medical records, which was a limitation because other 
covariates, which might have influenced the observed associations, such as the level of 
education or the home-based care providers' socioeconomic status, were not included due 
to lack of existing information.   
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Documentation of services offered in ART clinics is usually a challenge. Some of 
the files did not have complete information during data collection, while some had long-
outdated information. For example, in some clinics, many files did not have the 
information on the C&As care provider. Some service providers knew these individual 
care providers and worked with them to manage the C&As but did not document it. 
Hence, it could not be collected. Limited documentation at enrollment, which might have 
changed with time let to the missing values. I had to gather only the data reported in the 
records, as indicated in the study data collection plan. The documentation gaps led to 
high numbers of missing values for some indicators, which might have influenced the 
results. 
HIV Case identification and ART uptake in Cameroon is not yet optimal. This 
study included only children enrolled in care and did not include those living with HIV in 
the community whose status is unknown and those already tested HIV positive but not 
yet on ART. However, some of these children may not be in care due to their family 
status, long distances to ART clinics, high transport costs, and many other factors. This 
limits the generalizability of the findings to the general population. As a retrospective 
study, data collected was based on what was available, which did not give the same 
sample in each subgroup. The imbalance in study participants in each group could 
influence the results and the interpretation of findings.  
The study included only participants who had at least a documented viral load 
result during the period, which excludes those who did not have a viral load result. These 
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C&As without viral load might have different experiences and may be more likely to 
default from care than those in the study. 
Recommendations for further research 
The variables in this study were limited to what was available in the medical 
records onsite. A prospective study conducted in the same setting, which includes all 
possible predictors of retention, as seen in previous studies in addition to the model of 
care, may yield more reliable results. This is because data will be collected for possible 
confounders and effect modifiers which will all be included in the analysis. The level of 
investment in some care models calls for distinct outcomes. Otherwise, it may not be 
worth investing much in such models to achieve similar retention by the care model. 
Retention in big pediatric clinics seems to be a big issue, and since these clinics 
have large numbers of C&As, their performance pulls down that of the entire country. 
Conducting qualitative studies to understand C&As' plight and risk factors hindering 
retention despite all the investment is worthwhile. It may be essential to review the 
content of the care packages in the SGs and CAFCs and the level of fidelity they are 
implemented to identify why the viral suppression rates in these models are still 
suboptimal (<70%).  
There is a need to investigate whether associations between the independent 
variables in children compared to adolescents may yield different results and constitute a 
topic for further research. It was interesting to see that viral suppression did not differ by 
type of home-based care provider. Additional research, including qualitative studies on 
the topic, may uncover other underlying factors that contribute to the high viral load even 
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in C&As living with their biological parents, including some of the parents on ART. A 
further investigation into the package of services offered by each type of home-based 
care provider to the C&As and a review of the home environment without assuming that 
biological parents will do better than foster parents could also reveal significant findings 
that will contribute to the existing literature. 
Implications for Positive Social Change 
This study's findings are likely to stimulate further research in line with the 
recommendations outlined, leading to a positive change in the HIV domain. The results 
also can impact social change at the clinic, community, and health system levels. At the 
clinic level, the providers and care providers, upon receipt of the results, will be more 
determined to strengthen clinical and psychosocial services to improve retention and viral 
suppression in care while documenting all reasons for any client who will not be retained. 
All providers in the SCV model will likely seek to bring the children together for peer 
support since it is crucial in the other models. The dissemination of the findings in 
various sites will likely rekindle interest and commitment to pediatric HIV services 
onsite, and service providers will strengthen C&As' management for better outcomes. 
Service providers will likely enhance their knowledge of and collaboration with the 
home-based care provider of every C&As for improved adherence and psychosocial 
support at home.  
At the community level, the study findings may strengthen knowledge on the need 
for children living with HIV to stay healthy, the importance of being consistent on ART, 
and the importance of viral load monitoring, which tells how successful the HIV program 
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is. The increase in knowledge may increase the free of charge viral load testing since 
caregivers may begin requesting viral load sample collection for their C&As. As many 
more of the C&As do the viral load test when eligible, achieve sustained viral 
suppression, they will live healthy lives. Consequently, they will attend school regularly, 
their care providers will spend less money on health, less time in hospitals, and have 
more time to work and generate money for other family needs. 
There will be discussions of the findings at the organizational level that may lead 
to some redirection of funds to provide more support to C&As receiving care in the SCVs 
while strengthening supervision in the clinics with SGs and CAFCs to increase 
efficiency. New targets will likely be set for each clinic to achieve improved retention 
and viral suppression in the new year with improvement action plans drawn for each site. 
Home-based care providers will likely be brought together for education and peer support 
to strengthen their understanding of the role they must play to improve retention and viral 
suppression in the C&As. Their increased knowledge and involvement will likely 
improve the outcomes and increase the quality of life for the children and the community. 
This may lead to the generation of some ‘communities of practice," which will become 
best practices for emulating by others.  
At the health system level, the study findings are likely to cause the national 
pediatric HIV technical working group to rethink about the national pediatric HIV 
program, discuss study findings, other strengths and weaknesses and strategize for 
improved outcomes, which should include strengthened supervision and technical 
assistance, especially in the health facilities in remote areas. Improved services in the 
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health facilities in remote areas will limit referrals to big hospitals, reduce distances, and 
cost transport, reducing defaulting, consequently improving retention. Strengthened 
supervision and improved quality of care in the remote facilities in improving retention 
may also improve viral suppression rates, enabling the country to progress towards 
achieving the third 90 UNAIDS goal, aiming to have at least 90% of all patients on ART 
virally suppressed. 
The study was a retrospective study conducted within a short period with findings 
that are likely to generate several debates and further research around pediatric HIV 
services. According to the existing literature, few operational research studies are 
conducted in Cameroon compared to countries in East Africa, likely because potential 
researchers believe that much money is required to do a study. The design and findings 
from this study prove that operational studies are feasible with some effort and limited 
funds and could serve as evaluations of existing interventions and generate findings that 
may lead to policy change. It is likely that within the next year, there will be several other 
studies conducted in this domain to extend knowledge or counter these findings while 
contributing to the existing literature on the topic. The scale-up in operational research 
and the use of study findings for program improvement will increase the HIV program's 
visibility, leading to positive social change. Additionally, studies that identify best 
practices, strategies, and whose findings are used to improve program outcomes will 





 People living with HIV and on ART need to stay in care, take their medications 
consistently, and achieve viral suppression, which will keep them healthy and reduce 
viral transmission. Unfortunately, the retention and viral suppression rates in C&As have 
been suboptimal despite efforts to improve them in Cameroon. This study examined the 
association of the model of care and the type of home-based care provider to retention at 
12 months and viral suppression while controlling for age and sex. Findings showed that 
the children enrolled in CAFCs had a higher viral suppression rate compared to the other 
models, pointing to the need to strengthen clinical management and psychosocial support 
for the C&As at all levels. The care model did not seem to have an association with the 
12 months retention in care. The type of care provider at home did not also affect viral 
suppression and consistency of medication pickup. A better understanding of the models 
that yield better results, the care package's content, and home-based care providers' role 
are essential. The translation of this understanding into remediation action plans for 
effective implementation may speed up progress towards the UNAIDS third 90 in 
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